Literature DB >> 30429537

Blocking nuclear export of HSPA8 after heat shock stress severely alters cell survival.

Fengjuan Wang1, Srinivasa Reddy Bonam1, Nicolas Schall1, Lauriane Kuhn2, Philippe Hammann2, Olivier Chaloin3, Jean-Baptiste Madinier1, Jean-Paul Briand1, Nicolas Page4, Sylviane Muller5,6.   

Abstract

The nuclear translocation of endogenous heat shock cognate protein HSPA8 is a requisite for cell survival during oxidative and heat shock stress. Upon these events, cytoplasmic HSPA8 is thought to concentrate within the nucleus and nucleolus. When the situation returns to normal, HSPA8 is released from its nuclear/nucleolar anchors and redistributes into the cytoplasm. By using different stress conditions and a 21-mer phosphopeptide tool called P140, which binds HSPA8 and hampers its chaperone properties, we deciphered the cellular and molecular effects arising during this vital cytoplasmic-nuclear-cytoplasmic shuttling process. Using the non-metastatic fibroblastoid cell line MRL/N-1 derived from a MRL/MpTn-gld/gld lupus-prone mouse, we discovered that P140 treatment neutralized the egress of HSPA8 from nucleus to cytoplasm in the cell recovery phase. This lack of relocation of HSPA8 into the cytoplasm of heat-shocked MRL/N-1 cells altered the ability of these cells to survive when a second mild oxidative stress mimicking inflammatory conditions was applied. Crosslinking experiments followed by proteomics studies showed that P140 binds regions close to nuclear import and export signal sequences encompassed within the HSPA8 structure. These data are consistent with HSPA8 having a crucial cell protective role against reactive oxygen species (ROS) production by mitochondria during inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30429537      PMCID: PMC6235846          DOI: 10.1038/s41598-018-34887-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


Introduction

In contrast to cytoplasmic HSP70s that are generated in response to stress, proteins of the HSPA8/HSC70 family are constitutively expressed. They exhibit pleiotropic properties and are crucial for cell survival[1,2]. In particular, HSPA8 proteins participate to the folding of nascent proteins or refolding of altered proteins, and to their targeting to the ubiquitin/proteasome machinery for degradation. HSPA8 is involved in protein import into organelles or cellular compartments. Under normal conditions, cytoplasmic HSPA8 shuttles between the cytoplasm and the nucleus in an ATP-dependent manner[3], a property that enables HSPA8 to import different cytoplasmic (client) proteins into the nucleus[4]. To translocate within the nucleus, HSPA8 either interacts with nuclear localization sequence (NLS)-containing proteins or exploits its own NLS. At least two NLS sequences have been identified so far in human HSPA8, both located within the nucleotide binding domain[5-7]. They are present in residues 69-DAKRL-73 in the N-terminus and 246-KRKHKKDISENKRAVRR-262 in the ATPase domain of HSPA8. A nucleolar localization signal (NoLS) sufficient to promote nucleolar targeting in response to heat shock (HS) was identified in residues 225–244 of HSPA8[8]. Within the tertiary structure of the N-terminal HSPA8 ATPase domain (nucleotide-binding domain, NBD), this segment is located within the domain B of lobe II, which encompasses residues 229–306[9,10]. The shuttling capacity of HSPA8 also contributes to the cytosolic export of nuclear proteins, a mechanism that requires energy input[11]. A nuclear export signal (NES) motif has been identified in residues 394–401 of HSPA8 at the very N-terminus of substrate-binding domain[7]. The signaling pathways involved in HSPA8 trafficking in case of stress are not known in all details. While HSPA8 normally shuttles between the cytoplasm (where it is extremely abundant) and the nucleus, in case of heat-induced stress, its nuclear export is transiently inhibited, confining HSPA8 within the nucleus[12]. In certain stress conditions, notably when cells are exposed to HS or oxidative stress produced by hydrogen peroxide (H2O2), HSPA8 can concentrate in nucleoli. When the physiological situation returns to normal (recovery phase from stress), HSPA8 proteins are released from nuclear and nucleolar anchors and its shuttling to cytoplasm is restored. The duration of this process (in the range of several hours) varies according to the type of cells and stress. It has been described that confluent or high density cell cultures could have negative impact on nucleocytoplasmic trafficking of HSPA8, thereby preventing its nuclear import[13]. Several pharmacological inhibitors were also found to hamper HSPA8 import or export. Thus, the phosphoinositide 3-kinase inhibitor LY294002 was used to demonstrate (partial) inhibition of nucleolar accumulation of HSPA8 during the recovery phase[8]. Indomethacin and Ibuprofen, which are non-steroidal anti-inflammatory drugs, have been shown to mobilize HSPA8 in the cell nucleus[14]. Having in hands an original peptide, called P140, which was found to readily bind HSPA8 both in vitro and in vivo, to interact with the NBD of HSPA8 and shown to inhibit some of the protein functions[15-17], we addressed the question of whether P140 peptide could affect HSPA8 homing into nuclei and nucleoli under stress conditions and recovery, and what the cellular consequences would be. The uppermost interest of investigating this question with P140 originates from the fact that this peptide, a 21-mer fragment of the 70 kDa spliceosomal small nuclear ribonucleoprotein (SNRNP70/U1-70K) protein, is a potent immunomodulator of lupus disease as shown in lupus-prone MRL/lpr mice[18,19] and autoimmune patients with systemic lupus erythematosus[20]. It is currently evaluated in a phase III-clinical trial (program Lupuzor). Furthermore, knowing that HSPA8 also acts as a chaperone for class II major histocompatibility complex proteins[21-25], any alteration of its trafficking may potentially affect antigenic peptide presentation to the receptor of T cells, leading to a possible regulation of the downstream immune response. First, we found that according to the type of injury that was applied to cells (HS or oxidative stress), the cytoplasmic-nuclear shuttling capacities of HSPA8 were differently regulated. Then, using the P140 peptide as an HSPA8 binder, we unexpectedly discovered that in the presence of this peptide, HSPA8 did not egress from the nucleus to the cytoplasm in the cell recovery phase but remained sequestered into the nucleus. We found that one of the serious consequences of this defective relocation of HSPA8 into the cytoplasm was the inability of heat-shocked cells to survive after a second type of aggression, e.g. a mild oxidative stress that virtually mimics a state of inflammation. Crosslinking experiments followed by proteomics studies allowed us to demonstrate that these effects of P140 likely result from its binding to regions close to nuclear import and export signal sequences encompassed within the HSPA8 structure.

Results

Nucleocytoplasmic shuttling of endogenous HSPA8 in heat-shocked MRL/N-1 cells

While in unstressed conditions most of HSPA8 widely distributes inside the cytoplasm, it has been previously described that upon HS or oxidative stress, HSPA8 translocates into nucleus and transiently concentrates inside nucleolus. During recovery from stress conditions, nuclear HSPA8 relocates to cytoplasm[8]. In preliminary experiments performed by confocal microscopy and western immunoblotting (Fig. 1A,B; Fig. S1), we verified that this process did occur in the non-metastatic fibroblastoid cell line MRL/N-1. This cell line was selected for conducting our studies because it was derived from the spleen of an MRL/MpTn-gld/gld (MRL/gld) mouse[26,27], a murine model close to lupus-prone MRL/lpr mice in which our previous studies were conducted[15-19]. As MRL/lpr mice, MRL/gld mice are deficient in a functional Fas ligand and spontaneously develop autoimmune diseases involving both lethal glomerulonephritis and systemic arteritis. We effectively confirmed the whole process of HSPA8 nuclear/nucleolar import upon heat stress and cytoplasm relocation throughout the recovery phase in this cell line. Nucleus HSPA8 egress was detectable between 3 and 6 h onwards (Fig. 1B). As anticipated due to its large abundance in the cytoplasm[28,29], it was not possible to detect any variation of the HSPA8 (and HSP90) content in the cytoplasmic and total fraction (Figs S2 and S3).
Figure 1

P140 affects the nuclear translocation of HSPA8 upon heat shock. (A) Confocal fluorescence images of cellular HSPA8 upon HS and recovery in the presence or absence of P140. MRL/N-1 cells were exposed to HS (30 min; 45 °C), and allowed to recover at 37 °C for indicated time points (3 and 24 h) following HS, in the absence or presence of 10 µM P140. Cells were stained with HSPA8-PE antibody (in red). The nuclei were stained with DAPI (in blue). Transmission images showing the morphology of cells are presented in Fig. S1A. (B) Western immunoblotting of nuclear HSPA8 upon HS and recovery in the presence or absence of P140. MRL/N-1 cells were treated and allowed to recover as in (A). Cells were collected at the indicated time points of the recovery phase and subjected to cell fractionation to isolate the nuclear and cytoplasmic fractions. Nuclear HSPA8 only was analyzed here. Histone H3 was used as nuclear marker and β-tubulin as cytosolic marker. The relative amount of nuclear HSPA8 was analyzed by densitometry with Image J. The fold change was plotted by normalizing the nuclear HSPA8 amounts by that of the control after HS (value set to 1). Mean values with standard error of the mean (SEM) of five independent experiments are presented. Non-parametric two-way ANOVA was used to evaluate the statistical significance.

P140 affects the nuclear translocation of HSPA8 upon heat shock. (A) Confocal fluorescence images of cellular HSPA8 upon HS and recovery in the presence or absence of P140. MRL/N-1 cells were exposed to HS (30 min; 45 °C), and allowed to recover at 37 °C for indicated time points (3 and 24 h) following HS, in the absence or presence of 10 µM P140. Cells were stained with HSPA8-PE antibody (in red). The nuclei were stained with DAPI (in blue). Transmission images showing the morphology of cells are presented in Fig. S1A. (B) Western immunoblotting of nuclear HSPA8 upon HS and recovery in the presence or absence of P140. MRL/N-1 cells were treated and allowed to recover as in (A). Cells were collected at the indicated time points of the recovery phase and subjected to cell fractionation to isolate the nuclear and cytoplasmic fractions. Nuclear HSPA8 only was analyzed here. Histone H3 was used as nuclear marker and β-tubulin as cytosolic marker. The relative amount of nuclear HSPA8 was analyzed by densitometry with Image J. The fold change was plotted by normalizing the nuclear HSPA8 amounts by that of the control after HS (value set to 1). Mean values with standard error of the mean (SEM) of five independent experiments are presented. Non-parametric two-way ANOVA was used to evaluate the statistical significance.

P140 alters the nucleocytoplasmic shuttling of endogenous HSPA8 upon heat shock stress

We then repeated these experiments using MRL/N-1 cells incubated with 10 µM P140 peptide, and observed striking effects of the peptide on HSPA8 trafficking and cell growth. P140 slightly slowed down the entry of endogenous HSPA8 into the nucleus upon HS but more importantly, prolonged its sequestration in the nucleus/nucleoli upon the recovery phase (Fig. 1; Fig. S1A). These observations were confirmed in mouse embryonic fibroblasts (MEF) cells used as a second cell type to reinforce our findings (Fig. S4A). The level of HSPA8 in the cytosolic fraction of MRL/N-1 cells was diminished at 24 h compared to the cells that were not treated with P140 peptide (Fig. S2), the total amount of HSPA8 and HSP90 remained apparently unchanged (Fig. S3). Of note, P140 and ScP140 peptides had no effect on HSPA8 mRNA expression levels (Fig. S3E).

Nucleocytoplasmic shuttling of endogenous HSPA8 does not occur in MRL/N-1 cells subjected to a mild oxidative stress or to nutrient starvation

It is known that HS is the most efficient treatment to rapidly induce HSPA8 accumulation in nuclei. Depending on cell type and stressor compounds and also if short or prolonged exposure to stressors is applied, different effects can be observed on protein trafficking. A series of tests were therefore performed to examine the subcellular distribution of HSPA8 after an oxidative stress induced by H2O2. We observed that in contrast to what we found in HS stress conditions, mild oxidative stress induced with 100 µM H2O2 or with Paraquat (not a ROS by itself but generating oxygen radicals through the redox cycling mechanism), or nutrient starvation did not provoke HSPA8 translocation into the nucleus of MRL/N-1 cells and that P140 treatment had no effect on this process (Fig. S5, in the presence of H2O2; other data not shown).

Consequences of the P140-induced HSPA8 nuclear sequestration in heat-shocked cells

We have previously seen that in acute HS stress conditions, P140 peptide induces the sequestration of HSPA8 within the nucleus/nucleolus. Hence we wanted to determine whether this lack of return to normalcy might have any effect on cell behavior. First we examined the viability level of MRL/N-1 cells and their ability to grow. The percentage of propidium iodide positive (PI+) cells measured during the post-HS recovery period remained low (<10%) and was not affected by the presence of P140 peptide (Fig. 2A,B). This suggests that the integrity of plasma membrane of heat-shocked cells was preserved, that the basal number of necrotic (and apoptotic) cells was unaffected, and that the influence of P140 on HSPA8 trafficking did not provoke abnormal mortality. In contrast, however, cell counts measured over the recovery time were significantly reduced in the presence of P140 in the cultures (Fig. 2C,D) indicating that P140-induced sequestration of HSPA8 into the nucleus of HS-stressed MRL/N-1 cells altered their proliferation.
Figure 2

P140 does not affect cell survival but reduces cell growth of heat-shocked MRL/N-1 cells. Cell death percentage (A,B) or cell counts (C,D) of MRL/N-1 cells that were either kept at 37 °C at all time points (A,C) or heat-shocked and left at 37 °C for recovery (B,D) in the presence or not of 10 µM P140. Cell death was measured using PI staining and flow cytometry. Cell counts were determined using a LUNA-FL automated cell counter. Mean values ± SD of two independent experiments with triplicate samples are presented. Two-way ANOVA was used to evaluate the statistical significance.

P140 does not affect cell survival but reduces cell growth of heat-shocked MRL/N-1 cells. Cell death percentage (A,B) or cell counts (C,D) of MRL/N-1 cells that were either kept at 37 °C at all time points (A,C) or heat-shocked and left at 37 °C for recovery (B,D) in the presence or not of 10 µM P140. Cell death was measured using PI staining and flow cytometry. Cell counts were determined using a LUNA-FL automated cell counter. Mean values ± SD of two independent experiments with triplicate samples are presented. Two-way ANOVA was used to evaluate the statistical significance. It is well established that HSPA8 is involved in the progression of cell cycle during the G1/S transition, notably by regulating the nuclear accumulation of cyclin D1 that is central in G1 to S phase cell cycle transition and via its interaction with connexin 43[30-32]. Flow cytometry experiments with MRL/N-1 cells showed that upon HS, P140 had no effect on cell cycle (Fig. S6). No effect could be detectable either when the intensity of macroautophagy and chaperone-mediated autophagy (CMA) processes was studied (Fig. S7). Autophagy was investigated as HSPA8 plays key functions in this vital process, especially in CMA[2,33,34], and that abnormal overexpression in B cells from MRL/lpr lupus-prone mice of HSPA8 and lysosomal-associated membrane protein 2A (LAMP2A), another rate-limiting protein in CMA that is responsible for the selective degradation of cytosolic proteins in lysosomes, is down-regulated in P140-treated mice[16,17]. We found no change of the expression of microtubule-associated protein light chain-3 (LC3-II/MAP1LC3-II), sequestosome 1 (SQSTM1/p62; not shown), and LAMP2A in total lysates of HS-stressed MRL/N-1 cells incubated with or without P140. HSPA8 has also been shown to be essential for regulating cellular signaling and notably participates to Akt signaling pathway in endothelial cells[35]. It was also demonstrated that the nuclear translocation of HSPA8 requires the signaling events through the PI3-kinase → Akt and MEK → ERK1/2 pathways[8]. We therefore studied markers of these two kinase signaling cascades in non-stressed or HS-stressed cells, both in the presence or absence of P140 peptide. The latter showed no effect on the expression of PI3K and MEK-ERK1/2 markers (Fig. S8).

HSPA8 nuclear sequestration by P140 peptide makes the MRL/N-1 cells more vulnerable to stress conditions

Because HSPA8 translocation to nuclei/nucleoli is supposed to represent a protecting event against aggression, we subjected heat-shocked MRL/N-1 cells to a second set of stress. In the cultures that were not treated with P140 (Fig. 3, blue bars), we noted that after two sequential HS exposures, separated by 24 h recovery in fresh medium at 37 °C, cultures contained less than 10% PI+ cells, which is of the same order of magnitude as what was evaluated after a single HS period. Cell death was slightly raised, although not significantly, in the cultures that were sequentially exposed to an HS and then to an oxidative stress, separated by 24 h recovery. In this case, cell cultures contained about 20–25% PI+ cells and this effect was H2O2 dose-dependent. In the presence of P140 in the cultures (Fig. 3, red bars), the cell death level was impressively increased to reach up to 51.8 ± 4.2% PI+ cells, according to the H2O2 concentration added to the cultures (P = 0.0048 and P < 0.0001 in the presence of 100 or 200 µM H2O2, respectively). The thermosensitivity of P140-treated cells (second HS) was also altered but much more modestly (P = 0.0285). The control ScP140 peptide had no effect (Fig. 3; gray bars). The same phenomenon was observed in MEF cells (Fig. S4B).
Figure 3

P140 compromises heat-shocked cells upon a second mild oxidative stress. MRL/N-1 cells were heat-shocked and led to recover at 37 °C for 24 h in the presence or absence of P140 and control peptide ScP140. Another shock induced either by HS (30 min at 45 °C) or H2O2 (for 1 h) was then applied followed by a 24h-recovery time at 37 °C. Cell death was assessed using PI staining and flow cytometry. Mean values ± SD of two independent experiments with triplicates are presented. Two-way ANOVA was used to evaluate the statistical significance.

P140 compromises heat-shocked cells upon a second mild oxidative stress. MRL/N-1 cells were heat-shocked and led to recover at 37 °C for 24 h in the presence or absence of P140 and control peptide ScP140. Another shock induced either by HS (30 min at 45 °C) or H2O2 (for 1 h) was then applied followed by a 24h-recovery time at 37 °C. Cell death was assessed using PI staining and flow cytometry. Mean values ± SD of two independent experiments with triplicates are presented. Two-way ANOVA was used to evaluate the statistical significance. Altogether, our results support the view that by blocking the egress of HSPA8 chaperone from cell nuclei/nucleoli, P140 severely compromises the ability of cells to survive to a subsequent oxidative stress. These findings are of central importance since oxidative stress is one of the key manifestations of inflammation. These results may also be of underlying value to explain, at least in part, how P140 peptide leads to death of activated autoimmune cells[15,16].

P140 peptide alters HSPA8 trafficking by blocking the NLS and NES of the chaperone protein

One possible mechanism to explain the striking effect of P140 on HSPA8 trafficking would be that P140 alters the NLS and/or NES of HSPA8 either by direct interaction with these signal motifs or by indirectly affecting their availability. We tested this hypothesis by using a comparative proteomics analysis of HSPA8 alone and HSPA8-P140 complex. P140 peptide labeled with a sulfhydryl-reactive methanethiosulfonate (Mts)-ultra violet (UV) light-activable perfluorophenylazide (Atf)-biotin group was led to interact with either the full-length protein or the NBD HSC70 1–386 fragment (molar ratio 1:1) and UV-irradiated. This strategy generated covalent bonds between the photoactivable group and nearby HSPA8 residues. Cross-linking efficacy was checked after purification of the resulting complex and western immunoblotting (Fig. 4A). The sequence of HSPA8 peptides involved in P140 interaction was deduced from mass spectrometry analysis of fragments produced after in-gel trypsin digestion of purified cross-linked and non-cross-linked HSPA8 protein. Standardized matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF/TOF) acquisitions revealed trypsin cleavage differences when the cross-linked protein and the unreacted one were compared. Compared to the respective non-cross-linked samples, two peptides were not significantly recovered neither in the cross-linked Atf-biotin-HSPA8 protein nor in Atf-biotin-NBD fragment (triplicate experiments and three different MALDI deposits per experiment; Fig. 4B,C; Fig. S9). These two peptides encompassed residues 272–298 and 88–101, respectively. It is anticipated that the binding of P140 peptide to HSPA8 or to the NBD, directly or at distance, hampered trypsin cleavage of the C-terminal residue of these fragments. Interestingly, depiction of the segments 88–101 and 272–298 on the models of HSPA8 and NBD-BCL2 associated athanogene 1 (BAG-1) complex (Fig. 4D) showed that they are located in the vicinity of BAG-1 and ATP binding sites identified in the crystallographic structure of complexes[10,36-38]. They are also very close to the two NLS sequences that have been identified in residues 69–73 and 246–262[5-7] and the NoLS present in the segment 225–244[8] of the ATPase domain (or NBD) of HSPA8. It is possible that the binding of P140 to the NBD also indirectly affects the NES encompassed in the sequence 394–401 of the substrate-binding domain[7].
Figure 4

Cross-linking experiments to locate the binding site of P140 on HSPA8. (A) Western immunoblotting analysis showing HSPA8 protein after photo cross-linking experiments with Atf-biotin-P140 peptide (UV irradiation time is indicated in min). HSPA8 was transferred from denaturing gel to polyvinylidene difluoride membranes and stained with HRP-conjugated streptavidin, and developed with electrogenerated chemiluminescence detection reagent. (B) Positive reflectron MALDI-TOF spectra of HSPA8 NBD standardized as described in the materials and methods section. Trypsic digestion of NBD-containing fragment was monitored in the presence (right panel) or absence (left panel) of the cross-linking (one representative of three independent experiments with three spots/experiment). The arrows indicate the position of two peaks that vary in the cross-linked versus non-treated protein. (C) Sequence, mass and MALDI-TOF signal intensity ratios of each peptide generated in the presence or absence of cross-linking. The SD values were calculated from the 9 ratios (3 independent experiments with three spots/experiment). The ratios were considered as significant (red) if they were higher than a 3-fold change. (D) Left: depiction of the space-filling model of HSPA8 NBD showing the ATP pocket (blue) and the BAG-1-interacting domain (yellow). Right: Ribbon illustration of HSPA8 NBD with the amino acid sequences of interest highlighted. The location of NLS (green) and NoLS (cyan) motifs are highlighted (PDB code access 3HSC). The peptides 88–101 and 272–298, whose detection by MALDI-TOF experiments is influenced by the presence of cross-linking, are shown in fuchsia pink in both panels.

Cross-linking experiments to locate the binding site of P140 on HSPA8. (A) Western immunoblotting analysis showing HSPA8 protein after photo cross-linking experiments with Atf-biotin-P140 peptide (UV irradiation time is indicated in min). HSPA8 was transferred from denaturing gel to polyvinylidene difluoride membranes and stained with HRP-conjugated streptavidin, and developed with electrogenerated chemiluminescence detection reagent. (B) Positive reflectron MALDI-TOF spectra of HSPA8 NBD standardized as described in the materials and methods section. Trypsic digestion of NBD-containing fragment was monitored in the presence (right panel) or absence (left panel) of the cross-linking (one representative of three independent experiments with three spots/experiment). The arrows indicate the position of two peaks that vary in the cross-linked versus non-treated protein. (C) Sequence, mass and MALDI-TOF signal intensity ratios of each peptide generated in the presence or absence of cross-linking. The SD values were calculated from the 9 ratios (3 independent experiments with three spots/experiment). The ratios were considered as significant (red) if they were higher than a 3-fold change. (D) Left: depiction of the space-filling model of HSPA8 NBD showing the ATP pocket (blue) and the BAG-1-interacting domain (yellow). Right: Ribbon illustration of HSPA8 NBD with the amino acid sequences of interest highlighted. The location of NLS (green) and NoLS (cyan) motifs are highlighted (PDB code access 3HSC). The peptides 88–101 and 272–298, whose detection by MALDI-TOF experiments is influenced by the presence of cross-linking, are shown in fuchsia pink in both panels. Together, these data strongly suggest that by interacting with HSPA8, P140 peptide likely interferes with the signaling motifs, which are required for its nuclear and cytoplasmic translocation in stress conditions, altering therefore its trafficking, which is a key element of cell protection in case of stress. This mechanism is clearly differently regulated according to the nature of stress.

Does P140 interact with HSPA8 functions in the nucleus in vivo?

A last question remaining to solve in order to reinforce our assumption was to formally determine if P140 readily binds to HSPA8 in the nucleus of heat-shocked cells. Transmission electron microcopy (TEM) images clearly showed some dense large (HSPA8) and small (P140) gold particles that co-localized into the nucleus and perinucleus of PBMCs collected from MRL/lpr mice 1 h after intravenous injection of a biotinylated version of P140 peptide (Fig. 5; Fig. S10). These results indicate that P140 can translocate within the nucleus of cells where it can readily interact with HSPA8 and potentially block it activity as outlined above.
Figure 5

P140 peptide interacts with HSPA8 in the nucleus and hampers its functional activity. Co-localization of P140 and HSPA8 staining (red squares) as revealed by TEM in the nucleus/perinucleus (top panels) and in the cytosol (bottom left) of PBMCs collected from MRL/lpr mice that received the biotinylated P140 peptide via the intravenous route. Strings of small gold particles were also found in vesicles that might correspond to endosomes (bottom right). Immunolabeling was done using anti-biotin (for P140) and anti-HSPA8 antibodies followed by secondary antibodies. HSPA8, 15 nm-gold particles; P140, 6 nm-gold particles.

P140 peptide interacts with HSPA8 in the nucleus and hampers its functional activity. Co-localization of P140 and HSPA8 staining (red squares) as revealed by TEM in the nucleus/perinucleus (top panels) and in the cytosol (bottom left) of PBMCs collected from MRL/lpr mice that received the biotinylated P140 peptide via the intravenous route. Strings of small gold particles were also found in vesicles that might correspond to endosomes (bottom right). Immunolabeling was done using anti-biotin (for P140) and anti-HSPA8 antibodies followed by secondary antibodies. HSPA8, 15 nm-gold particles; P140, 6 nm-gold particles.

Discussion

Nucleocytoplasmic shuttling of HSPA8 is crucial to protect stressed cells from possible damages and ensure their survival when the alterations that are generated are moderate. In case of stress this “in and out” trafficking that occurs at a basal level under normal growth conditions is rapidly activated by some signals and molecular mechanisms that remain largely unknown[12]. As in contrast to other Hsps, the constitutively expressed HSPA8 protein is particularly abundant in the cytoplasm, its transient egress from the cytoplasm has relatively few functional effects if any. However, its location in the nucleus/nucleoli is vital. HSPA8 possesses a binding domain for client proteins and the three domains that compose the protein interact with an army of co-chaperones, such as HSP90. When HSPA8 is going to hide in the nucleus/nucleoli of stress cells, it carries with it and protects metabolically important cell components that are required for assuring cell homeostasis and dynamics. It is why, not only the nuclear shuttling of HSPA8 but also its cytoplasmic release in the recovery phase is crucial. Numerous candidate proteins may thus been protected by the HSPA8 chaperone. These proteins can be of cytosolic origin but also, such as the nucleolar protein nucleolin[39], localized at the cell surface. Using the P140 peptide as a tool that binds HSPA8 and inhibits some of its functions, especially its chaperoning properties[15-17], we report here that blocking nuclear export of HSPA8 and its client proteins in the post-HS stress recovery phase is deleterious for cell survival. Unexpectedly, the lack of normalcy restoration of HSPA8 location in the cytoplasm has no effects on cell integrity if a second HS effect is applied and does not affect the cell cycle machinery or certain key pathways of autophagy or of cell signaling such as the PI3K-Akt and Ras-Raf-MEK-ERK pathways. However, when an oxidative stress is subsequently applied after HS, even if a period of total recovery is allowed to occur between the two sets of shock, then cells show vulnerability and die. This series of events is remarkable since the oxidative stress we applied (submillimolar levels of H2O2) caused no effect when it was given alone without prior HS stress. Therefore, we show that the morphological and metabolic changes that likely occur when H2O2 is added to pre-sensitized heat-shocked cells dramatically affect the integrity of cells in which the HSPA8 nucleocytoplasmic repartition is not at its steady-state level. Such senescence-like morphological changes have been demonstrated previously in mouse gingival fibroblasts[40]. DNA lesions were also observed when low concentrations of H2O2 were used[41]. Since we know that HSPA8 is a necessary cofactor for ubiquitination and degradation of a number of cellular proteins[42], a lower availability of HSPA8 might affect the ubiquitin-mediated proteasomal degradation pathway, an important mechanism to control protein load in the cells. It could also have altered macro- and chaperone-mediated autophagy processes, an effect that was however not demonstrate in our studies. This lack of apparent consequence is probably related to the huge amount of HSPA8 that resides in the cytoplasm. The P140 peptide tool was of instrumental value to reveal the crucial cell protective role of HSPA8 in stress conditions. A complete knock-down of HSPA8 (e.g. with siRNA) results in a massive cell death. P140, however, acts in a more subtle way. On a mechanistic point of view, we demonstrated that P140 binds to sites that may affect HSPA8 translocation, in particular in its exportation phase to the cytoplasm during the recovery phase. As we know that P140 binds to residues in the NBD[17], it should not affect the oligomeric state of HSPA8 that involves the C-terminus of the protein[43,44]. Accumulating studies have pointed out the potential of blocking HSP70 family members to a therapeutic way of intervention, especially in cancer, autoimmunity and neurodegeneration[1,2,14,44-46]. HSPA8 is effectively involved in MHC class II antigen presentation[21-25] and as such, the level of its expression potentially modulates the downstream immune response. HSPA8 is also centrally implicated in highly regulated processes of cell death. To exploit the degradative outcome of stressed cells by P140 peptide might therefore constitute a valuable therapeutic strategy for precisely targeting sensitized cells and precipitate them into a cell death circuit. Alone on normal cells, P140 displays no apparent effect; its action on stressed cells, however, could be decisive to specifically eliminate distressed, sensitized cells.

Methods

Synthetic peptides and HSPA8

P140 peptide and scP140 analogue, as well as P140 peptide containing an additional cysteine residue at its N-terminus, biotinylated P140 and AlexaFluor 488 Cys-P140 were synthesized and purified as described[17]. Their homogeneity was checked by analytical high performance liquid chromatography (HPLC), and their identity was assessed by LC/MS on a Finnigan LCQ Advantage Max system (Thermo Fischer Scientific). Conjugation of the Mts-Atf-biotin reagent (Pierce) with SH group of the Cys-P140 peptide was performed as described by the manufacturer. After completion of the reaction, the conjugated Mts-Atf-Biotin-P140 peptide was purified by HPLC. Cloning, expression and purification of the recombinant human HSPA8 and HSPA8 NBD fragment were described previously[17].

Cell culture

MRL/N-1 cells were obtained from Tetsuya Kodama, Tohoku University School of Medicine, Japan. They were routinely cultured in Roswell Park Memorial Institute medium (RPMI) 1640 buffered-medium supplemented with 10% (v/v) fetal bovine serum (Dutscher), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) and gentamycin (10 µg/ml; Lonza BioWhittaker). The absence of mycoplasma contamination was systematically ensured.

Heat shock and oxidative stresses and recovery

MRL/N-1 cells were seeded for at least 6 h before further treatment. They were pre-treated or not with 10 µM P140 for 16 h, then transferred at 45 °C for 30 min (HS) and subsequently allowed to recover at 37 °C for indicated time points. P140 peptide was present all along the time, during the HS step and cell recovery. Oxidative stress was induced with 100 µM H2O2 (Sigma).

Fluorescence imaging

After treatment, cells were fixed and permeabilized with 100% (v/v) pre-cooled methanol at −20 °C, followed by incubation with phycoerythrin (PE)-labeled antibody to HSPA8 (Abcam, ab65170) overnight at 4 °C. The nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). Cells were then mounted with mounting medium (DAKO) and subjected to fluorescence imaging using a spinning-disc confocal microscope consisting of a CSU confocal spinning disk unit (Yokogawa), an Electron Multiplying Charge Coupled Device (EMCCD) Evolve camera (Roper Scientific), mounted on an Axio Observer Z1 microscope (Zeiss). 405 and 561 nm lasers, 420–470 nm band pass and 570–640 nm band pass emission filters were used to image the DAPI and HSPA8-PE, respectively. Quantification of fluorescence signals was done as described in Fig. S1B in using Image J software (National Institutes of Health).

Electron microscopy

The methods used have been described in details previously[15,16]. Freshly isolated PBMCs from 9-week-old MRL/lpr mice that received 100 µg biotinylated P140 or ScP140 peptides intravenously were collected 1 h post-injection, washed and fixed in 4% (v/v) paraformaldehyde and 0.2% (v/v) glutaraldehyde in 0.1 M phosphate-buffered saline (PBS) for 1 h at room temperature (RT). Cells were embedded in 1% (w/v) agarose, permeabilized with 0.2% saponin for 10 min, washed and saturated with 2% (w/v) bovine serum albumin and 0.2% (w/v) water fish skin gelatin (Sigma) in Tris-buffered saline. HSPA8 was revealed by using anti-HSPA8 rat monoclonal antibody (1:200; clone 1B5; Abcam) and goat anti-rat IgG conjugated to 15 nm-gold particles (Aurion); P140 and ScP140 were revealed with anti-biotin antibodies conjugated to 6 nm-gold particles. Ultrathin sections were stained with uranyl acetate and lead citrate and examined by TEM using a Hitachi H600 microscope. Images were acquired using a CDD camera (Hamamatsu).

Cell fractionation and western blot analysis

Cell fractionation, all along performed at 4 °C or on ice, was done as described[47]. Briefly, 500,000 MRL/N-1 cells were collected after treatment with trypsin, followed by one wash with cold PBS and then lyzed with lysis buffer [50 mM Tris-HCl, pH 7.0, 0.5% (v/v) Triton X-100, 137.5 mM NaCl, 10% (v/v) glycerol, 5 mM EDTA, supplemented with fresh protease inhibitors] on ice for 15 min. The nuclear pellet collected after a 5-min centrifugation at 800 g was washed twice in the lysis buffer and centrifuged at 800 g, and finally lyzed in 0.5% (v/v) sodium dodecyl sulfate (SDS)/lysis buffer (“nuclear” fractions). The supernatant was collected and centrifuged at 16,000 g for 10 min to obtain the clean “cytosolic” fraction. The protein concentration of both fractions was estimated with the Pierce BCA (bicinchoninic acid) protein assay (Thermo Fisher Scientific). Nuclear and cytoplasmic cellular fractions were mixed with Laemmli buffer (BioRad) and denatured for 10 min at 95 °C. The proteins were resolved by SDS-PAGE using 4–20% pre-casted gels (BioRad) and then transferred onto polyvinylidene difluoride membranes (BioRad) for immunoblot experiments. Autophagy activity was measured as described[48] Antibodies against HSPA8 (Abcam, ab19136), HSP90 (Abcam, ab13492), histone H3- horseradish peroxidase (HRP, Cell Signaling, 5192), phospho-Akt (Cell Signaling, 9271), phospho-ERK (Cell Signaling, 9101), SQSTM1/p62 (Abcam, ab109012), LC3-II/MAP1LC3-II (MBL International Corporation, M186–3), and LAMP2A (Abcam, ab18528) were used at the indicated dilutions. HRP-conjugated secondary antibodies and an enhanced chemiluminescence method (ECL, BioRad 1705060) were used to reveal the reactions. Protein densitometry was normalized to β-Tubulin loading control (Abcam, ab21058). Protein densitometry was normalized to either the level of H3 (Cell Signaling, 12648) for nuclear fractions or that of β-Tubulin (Abcam, ab21058) for cytosolic and total fractions.

Cell death measurement and cell counting

The fluorescent exclusion dye PI (Sigma, P4864) was used to label the nucleus in dying cell. Permeability to PI was evaluated by flow cytometer (PI+ cells; FACSCalibur, BD Biosciences). The cell number was counted using a LUNA-FLTM automated cell counter (Logos Biosystems) following the manufacturer’s instructions.

Cell cycle

MRL/N-1 cells were fixed in ice cold 70% (v/v) ethanol at 4 °C overnight followed by 3 washes in PBS and samples were treated with 0.1% (v/v) Triton X/PBS permeabilization buffer supplemented with 100 µg/ml RNase A (Sigma), at 37 °C for 15 min. 7-AAD (BD Pharmingen, 559925; 25 µg/mL) was added to stain the DNA, and samples were measured using a BD FACSCalibur flow cytometer (BD Biosciences) and analyzed using FlowJo software (Tree Star).

qPCR

The mRNA of MRL/N-1 cells treated with P140 or ScP140 for indicated times and concentrations were extracted using RNeasy Mini kit (Qiagen, 75704) according to manufacturer’s instructions. The first strand cDNA was synthetized from 200 ng of RNA using ImProm-II Reverse Transcriptase and oligo(dT)15 (Promega, A3802 and C1101). Ten ng of cDNA were then amplified using Taqman Real-Time PCR Master Mixes (ThermoFisher Scientific, 10525395), followed by qPCR analysis of the cDNA amount using the StepOneTM real-time PCR system (ThermoFisher Scientific). The primers for Hspa8 (4448892) and endogenous controls, Actb (4453320), Gusb (4453320) and Hprt1 (4453320) were purchased from ThermoFisher Scientific. The data analysis was done using the correspondent StepOneTM software and the amount of Hspa8 level was normalized with the levels of the three endogenous controls.

Cross-linking experiments

To identify the binding sites of P140 to HSPA8, 20 µL of recombinant HSPA8 or NBD (20 µM) and 20 µL of P140-Atf peptide (20 µM) corresponding to a 1:1 molar ratio of P140 peptide and HSPA8 protein/NBD fragment were incubated for 30 min at 37 °C in 100 mM Tris-HCl pH 7.4, 6 mM MgCl2 and 20 mM KCl. The resulting solution was then UV-irradiated at 365 nm for 20 min at 4 °C. The UV lamp (Bioblock Scientific, VL-4C) was placed at 2 cm above the sample. The complexes formed between the Atf-biotin-P140 and HSPA8 were isolated by purification of the extracts using 100 µL avidin-agarose (ImmunoPure Immobilized Avidin, Pierce) in PBS. After overnight incubation at 4 °C, the samples were washed extensively with the same buffer. The purified proteins were subjected to SDS-PAGE and revealed by colloidal blue staining. In some experiments, the efficiency of photo cross-linking was evaluated by western blotting using peroxidase-labeled streptavidin. The identification of HSPA8 peptide involved in P140 peptide interaction was deduced from mass spectrometry analysis as described below after cutting bands of interest. The in-gel digestion procedure was carried out as described[49]. Briefly, gel bands were washed alternately with 100 µL of 25 mM NH4HCO3 and then 100 µL of 50% (v/v) acetonitrile (ACN) (3 min wash under shaking and the liquid was discarded before addition of the next solvent). This hydrating/dehydrating cycle was repeated twice and the pieces of gel were dried for 20 min before reduction (10 mM dithiothreitol/25 mM NH4HCO3 for 45 min at 56 °C) and alkylation (25 mM iodoacetamide/25 mM NH4HCO3 for 45 min at RT). Gel spots were washed again with 3 cycles of 25 mM NH4HCO3/ACN, alternately. Following a 20 min-drying step, the gel pieces were rehydrated by three volumes of trypsin (Promega, V5111), 12.5 ng/µL freshly diluted in 25 mM NH4HCO3 buffer and incubated overnight at RT. Tryptic peptides were extracted from gel by vigorous shaking for 30 min in adapted volume of 35% H2O/60% ACN/5% HCOOH and a 15-min sonication step. MALDI mass measurements were carried out on an Autoflex III Smartbeam MALDI-TOF/TOF spectrometer (Bruker-Daltonik) used in positive mode, over a mass range of 700–4,000 Da (reflector mode) and 700–8000 Da (linear mode). A pre-spotted anchor chip target (PAC system, Bruker-Daltonik, technical note TN011) with HCCA matrix was used to analyse tryptic digests. In order to compare MALDI spectra for the whole set of samples, laser intensity was set to the same value for all of them (no deflection from the baseline and average resolution of 8,000 over the whole mass range), as well as the number of shots (sum of 2,000 shots by group of 500 shots). Moreover, three different MALDI deposits and mass measurements were made for each sample and a ratio was determined according to signals intensities for each condition (cross-linked protein and non-cross-linked protein).

Structure depiction

The spacing filling and ribbon model of HSPA8 NBD (PDB: 3HSC) was depicted using PyMOL software.

Statistical analyses

Statistical analyses were performed using GraphPad Prism version 5.0. Depending on the number of samples that were included in the analyses, statistical significances were assessed using the parametric Student’s t-test or the non-parametric Mann-Whitney’s test when one parameter was included. Two-way ANOVA was used when two parameters were compared. Depending on the number of samples, non-parametric or parametric were used. P values less than 0.05 were considered significant. In crosslinking experiments, the standard deviation (SD) values were calculated from the 9 ratios (3 independent experiments with three spots per experiment). The ratios were considered as significant if they were higher than a 3-fold change.

Ethics Statement

Animal protocols were carried out with the approval of the local Institutional Animal Care and Use Committee (CREMEAS, Strasbourg, France) and the French Ministère de l’Enseignement Supérieur de la recherche et de l’innovation (procédure APAFiS, autorisation de projet utilisant des animaux à des fins scientifiques). According to our agreement, and taking into account the best European practices in the field, we took the necessary measures to avoid pain and minimize the distress and useless suffering of mice during the time of experiment and killing process. Supplementary Dataset 1
  49 in total

1.  The carboxyl-terminal lobe of Hsc70 ATPase domain is sufficient for binding to BAG1.

Authors:  L Brive; S Takayama; K Briknarová; S Homma; S K Ishida; J C Reed; K R Ely
Journal:  Biochem Biophys Res Commun       Date:  2001-12-21       Impact factor: 3.575

2.  Nucleolar targeting of the chaperone hsc70 is regulated by stress, cell signaling, and a composite targeting signal which is controlled by autoinhibition.

Authors:  Piotr Bański; Hicham Mahboubi; Mohamed Kodiha; Sanhita Shrivastava; Cynthia Kanagaratham; Ursula Stochaj
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  Structural basis of interdomain communication in the Hsc70 chaperone.

Authors:  Jianwen Jiang; Kondury Prasad; Eileen M Lafer; Rui Sousa
Journal:  Mol Cell       Date:  2005-11-23       Impact factor: 17.970

4.  Ubiquitin-dependent degradation of certain protein substrates in vitro requires the molecular chaperone Hsc70.

Authors:  B Bercovich; I Stancovski; A Mayer; N Blumenfeld; A Laszlo; A L Schwartz; A Ciechanover
Journal:  J Biol Chem       Date:  1997-04-04       Impact factor: 5.157

5.  Constitutively expressed rat mRNA encoding a 70-kilodalton heat-shock-like protein.

Authors:  K O'Malley; A Mauron; J D Barchas; L Kedes
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

6.  Identification of novel nuclear export and nuclear localization-related signals in human heat shock cognate protein 70.

Authors:  Fujiko Tsukahara; Yoshiro Maru
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

7.  Computational analysis of the human HSPH/HSPA/DNAJ family and cloning of a human HSPH/HSPA/DNAJ expression library.

Authors:  Jurre Hageman; Harm H Kampinga
Journal:  Cell Stress Chaperones       Date:  2008-08-07       Impact factor: 3.667

8.  HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins.

Authors:  I Auger; J M Escola; J P Gorvel; J Roudier
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

9.  The 70-kD heat shock cognate protein (hsc70) facilitates the nuclear export of the import receptors.

Authors:  Shingo Kose; Maiko Furuta; Makiko Koike; Yoshihiro Yoneda; Naoko Imamoto
Journal:  J Cell Biol       Date:  2005-10-03       Impact factor: 10.539

10.  The spliceosomal phosphopeptide P140 controls the lupus disease by interacting with the HSC70 protein and via a mechanism mediated by gammadelta T cells.

Authors:  Nicolas Page; Nicolas Schall; Jean-Marc Strub; Marc Quinternet; Olivier Chaloin; Marion Décossas; Manh Thong Cung; Alain Van Dorsselaer; Jean-Paul Briand; Sylviane Muller
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  13 in total

1.  Heat shock cognate protein 70 promotes the differentiation of C2C12 myoblast and targets Yin Yang 1.

Authors:  Lei Chen; Tao Guo; Yan Yu; Yeqing Sun; Guangrong Yu; Liming Cheng
Journal:  Ann Transl Med       Date:  2019-10

2.  Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.

Authors:  Daniel J Klionsky; Amal Kamal Abdel-Aziz; Sara Abdelfatah; Mahmoud Abdellatif; Asghar Abdoli; Steffen Abel; Hagai Abeliovich; Marie H Abildgaard; Yakubu Princely Abudu; Abraham Acevedo-Arozena; Iannis E Adamopoulos; Khosrow Adeli; Timon E Adolph; Annagrazia Adornetto; Elma Aflaki; Galila Agam; Anupam Agarwal; Bharat B Aggarwal; Maria Agnello; Patrizia Agostinis; Javed N Agrewala; Alexander Agrotis; Patricia V Aguilar; S Tariq Ahmad; Zubair M Ahmed; Ulises Ahumada-Castro; Sonja Aits; Shu Aizawa; Yunus Akkoc; Tonia Akoumianaki; Hafize Aysin Akpinar; Ahmed M Al-Abd; Lina Al-Akra; Abeer Al-Gharaibeh; Moulay A Alaoui-Jamali; Simon Alberti; Elísabet Alcocer-Gómez; Cristiano Alessandri; Muhammad Ali; M Abdul Alim Al-Bari; Saeb Aliwaini; Javad Alizadeh; Eugènia Almacellas; Alexandru Almasan; Alicia Alonso; Guillermo D Alonso; Nihal Altan-Bonnet; Dario C Altieri; Élida M C Álvarez; Sara Alves; Cristine Alves da Costa; Mazen M Alzaharna; Marialaura Amadio; Consuelo Amantini; Cristina Amaral; Susanna Ambrosio; Amal O Amer; Veena Ammanathan; Zhenyi An; Stig U Andersen; Shaida A Andrabi; Magaiver Andrade-Silva; Allen M Andres; Sabrina Angelini; David Ann; Uche C Anozie; Mohammad Y Ansari; Pedro Antas; Adam Antebi; Zuriñe Antón; Tahira Anwar; Lionel Apetoh; Nadezda Apostolova; Toshiyuki Araki; Yasuhiro Araki; Kohei Arasaki; Wagner L Araújo; Jun Araya; Catherine Arden; Maria-Angeles Arévalo; Sandro Arguelles; Esperanza Arias; Jyothi Arikkath; Hirokazu Arimoto; Aileen R Ariosa; Darius Armstrong-James; Laetitia Arnauné-Pelloquin; Angeles Aroca; Daniela S Arroyo; Ivica Arsov; Rubén Artero; Dalia Maria Lucia Asaro; Michael Aschner; Milad Ashrafizadeh; Osnat Ashur-Fabian; Atanas G Atanasov; Alicia K Au; Patrick Auberger; Holger W Auner; Laure Aurelian; Riccardo Autelli; Laura Avagliano; Yenniffer Ávalos; Sanja Aveic; Célia Alexandra Aveleira; Tamar Avin-Wittenberg; Yucel Aydin; Scott Ayton; Srinivas Ayyadevara; Maria Azzopardi; Misuzu Baba; Jonathan M Backer; Steven K Backues; Dong-Hun Bae; Ok-Nam Bae; Soo Han Bae; Eric H Baehrecke; Ahruem Baek; Seung-Hoon Baek; Sung Hee Baek; Giacinto Bagetta; Agnieszka Bagniewska-Zadworna; Hua Bai; Jie Bai; Xiyuan Bai; Yidong Bai; Nandadulal Bairagi; Shounak Baksi; Teresa Balbi; Cosima T Baldari; Walter Balduini; Andrea Ballabio; Maria Ballester; Salma Balazadeh; Rena Balzan; Rina Bandopadhyay; Sreeparna Banerjee; Sulagna Banerjee; Ágnes Bánréti; Yan Bao; Mauricio S Baptista; Alessandra Baracca; Cristiana Barbati; Ariadna Bargiela; Daniela Barilà; Peter G Barlow; Sami J Barmada; Esther Barreiro; George E Barreto; Jiri Bartek; Bonnie Bartel; Alberto Bartolome; Gaurav R Barve; Suresh H Basagoudanavar; Diane C Bassham; Robert C Bast; Alakananda Basu; Henri Batoko; Isabella Batten; Etienne E Baulieu; Bradley L Baumgarner; Jagadeesh Bayry; Rupert Beale; Isabelle Beau; Florian Beaumatin; Luiz R G Bechara; George R Beck; Michael F Beers; Jakob Begun; Christian Behrends; Georg M N Behrens; Roberto Bei; Eloy Bejarano; Shai Bel; Christian Behl; Amine Belaid; Naïma Belgareh-Touzé; Cristina Bellarosa; Francesca Belleudi; Melissa Belló Pérez; Raquel Bello-Morales; Jackeline Soares de Oliveira Beltran; Sebastián Beltran; Doris Mangiaracina Benbrook; Mykolas Bendorius; Bruno A Benitez; Irene Benito-Cuesta; Julien Bensalem; Martin W Berchtold; Sabina Berezowska; Daniele Bergamaschi; Matteo Bergami; Andreas Bergmann; Laura Berliocchi; Clarisse Berlioz-Torrent; Amélie Bernard; Lionel Berthoux; Cagri G Besirli; Sebastien Besteiro; Virginie M Betin; Rudi Beyaert; Jelena S Bezbradica; Kiran Bhaskar; Ingrid Bhatia-Kissova; Resham Bhattacharya; Sujoy Bhattacharya; Shalmoli Bhattacharyya; Md Shenuarin Bhuiyan; Sujit Kumar Bhutia; Lanrong Bi; Xiaolin Bi; Trevor J Biden; Krikor Bijian; Viktor A Billes; Nadine Binart; Claudia Bincoletto; Asa B Birgisdottir; Geir Bjorkoy; Gonzalo Blanco; Ana Blas-Garcia; Janusz Blasiak; Robert Blomgran; Klas Blomgren; Janice S Blum; Emilio Boada-Romero; Mirta Boban; Kathleen Boesze-Battaglia; Philippe Boeuf; Barry Boland; Pascale Bomont; Paolo Bonaldo; Srinivasa Reddy Bonam; Laura Bonfili; Juan S Bonifacino; Brian A Boone; Martin D Bootman; Matteo Bordi; Christoph Borner; Beat C Bornhauser; Gautam Borthakur; Jürgen Bosch; Santanu Bose; Luis M Botana; Juan Botas; Chantal M Boulanger; Michael E Boulton; Mathieu Bourdenx; Benjamin Bourgeois; Nollaig M Bourke; Guilhem Bousquet; Patricia Boya; Peter V Bozhkov; Luiz H M Bozi; Tolga O Bozkurt; Doug E Brackney; Christian H Brandts; Ralf J Braun; Gerhard H Braus; Roberto Bravo-Sagua; José M Bravo-San Pedro; Patrick Brest; Marie-Agnès Bringer; Alfredo Briones-Herrera; V Courtney Broaddus; Peter Brodersen; Jeffrey L Brodsky; Steven L Brody; Paola G Bronson; Jeff M Bronstein; Carolyn N Brown; Rhoderick E Brown; Patricia C Brum; John H Brumell; Nicola Brunetti-Pierri; Daniele Bruno; Robert J Bryson-Richardson; Cecilia Bucci; Carmen Buchrieser; Marta Bueno; Laura Elisa Buitrago-Molina; Simone Buraschi; Shilpa Buch; J Ross Buchan; Erin M Buckingham; Hikmet Budak; Mauricio Budini; Geert Bultynck; Florin Burada; Joseph R Burgoyne; M Isabel Burón; Victor Bustos; Sabrina Büttner; Elena Butturini; Aaron Byrd; Isabel Cabas; Sandra Cabrera-Benitez; Ken Cadwell; Jingjing Cai; Lu Cai; Qian Cai; Montserrat Cairó; Jose A Calbet; Guy A Caldwell; Kim A Caldwell; Jarrod A Call; Riccardo Calvani; Ana C Calvo; Miguel Calvo-Rubio Barrera; Niels Os Camara; Jacques H Camonis; Nadine Camougrand; Michelangelo Campanella; Edward M Campbell; François-Xavier Campbell-Valois; Silvia Campello; Ilaria Campesi; Juliane C Campos; Olivier Camuzard; Jorge Cancino; Danilo Candido de Almeida; Laura Canesi; Isabella Caniggia; Barbara Canonico; Carles Cantí; Bin Cao; Michele Caraglia; Beatriz Caramés; Evie H Carchman; Elena Cardenal-Muñoz; Cesar Cardenas; Luis Cardenas; Sandra M Cardoso; Jennifer S Carew; Georges F Carle; Gillian Carleton; Silvia Carloni; Didac Carmona-Gutierrez; Leticia A Carneiro; Oliana Carnevali; Julian M Carosi; Serena Carra; Alice Carrier; Lucie Carrier; Bernadette Carroll; A Brent Carter; Andreia Neves Carvalho; Magali Casanova; Caty Casas; Josefina Casas; Chiara Cassioli; Eliseo F Castillo; Karen Castillo; Sonia Castillo-Lluva; Francesca Castoldi; Marco Castori; Ariel F Castro; Margarida Castro-Caldas; Javier Castro-Hernandez; Susana Castro-Obregon; Sergio D Catz; Claudia Cavadas; Federica Cavaliere; Gabriella Cavallini; Maria Cavinato; Maria L Cayuela; Paula Cebollada Rica; Valentina Cecarini; Francesco Cecconi; Marzanna Cechowska-Pasko; Simone Cenci; Victòria Ceperuelo-Mallafré; João J Cerqueira; Janete M Cerutti; Davide Cervia; Vildan Bozok Cetintas; Silvia Cetrullo; Han-Jung Chae; Andrei S Chagin; Chee-Yin Chai; Gopal Chakrabarti; Oishee Chakrabarti; Tapas Chakraborty; Trinad Chakraborty; Mounia Chami; Georgios Chamilos; David W Chan; Edmond Y W Chan; Edward D Chan; H Y Edwin Chan; Helen H Chan; Hung Chan; Matthew T V Chan; Yau Sang Chan; Partha K Chandra; Chih-Peng Chang; Chunmei Chang; Hao-Chun Chang; Kai Chang; Jie Chao; Tracey Chapman; Nicolas Charlet-Berguerand; Samrat Chatterjee; Shail K Chaube; Anu Chaudhary; Santosh Chauhan; Edward Chaum; Frédéric Checler; Michael E Cheetham; Chang-Shi Chen; Guang-Chao Chen; Jian-Fu Chen; Liam L Chen; Leilei Chen; Lin Chen; Mingliang Chen; Mu-Kuan Chen; Ning Chen; Quan Chen; Ruey-Hwa Chen; Shi Chen; Wei Chen; Weiqiang Chen; Xin-Ming Chen; Xiong-Wen Chen; Xu Chen; Yan Chen; Ye-Guang Chen; Yingyu Chen; Yongqiang Chen; Yu-Jen Chen; Yue-Qin Chen; Zhefan Stephen Chen; Zhi Chen; Zhi-Hua Chen; Zhijian J Chen; Zhixiang Chen; Hanhua Cheng; Jun Cheng; Shi-Yuan Cheng; Wei Cheng; Xiaodong Cheng; Xiu-Tang Cheng; Yiyun Cheng; Zhiyong Cheng; Zhong Chen; Heesun Cheong; Jit Kong Cheong; Boris V Chernyak; Sara Cherry; Chi Fai Randy Cheung; Chun Hei Antonio Cheung; King-Ho Cheung; Eric Chevet; Richard J Chi; Alan Kwok Shing Chiang; Ferdinando Chiaradonna; Roberto Chiarelli; Mario Chiariello; Nathalia Chica; Susanna Chiocca; Mario Chiong; Shih-Hwa Chiou; Abhilash I Chiramel; Valerio Chiurchiù; Dong-Hyung Cho; Seong-Kyu Choe; Augustine M K Choi; Mary E Choi; Kamalika Roy Choudhury; Norman S Chow; Charleen T Chu; Jason P Chua; John Jia En Chua; Hyewon Chung; Kin Pan Chung; Seockhoon Chung; So-Hyang Chung; Yuen-Li Chung; Valentina Cianfanelli; Iwona A Ciechomska; Mariana Cifuentes; Laura Cinque; Sebahattin Cirak; Mara Cirone; Michael J Clague; Robert Clarke; Emilio Clementi; Eliana M Coccia; Patrice Codogno; Ehud Cohen; Mickael M Cohen; Tania Colasanti; Fiorella Colasuonno; Robert A Colbert; Anna Colell; Miodrag Čolić; Nuria S Coll; Mark O Collins; María I Colombo; Daniel A Colón-Ramos; Lydie Combaret; Sergio Comincini; Márcia R Cominetti; Antonella Consiglio; Andrea Conte; Fabrizio Conti; Viorica Raluca Contu; Mark R Cookson; Kevin M Coombs; Isabelle Coppens; Maria Tiziana Corasaniti; Dale P Corkery; Nils Cordes; Katia Cortese; Maria do Carmo Costa; Sarah Costantino; Paola Costelli; Ana Coto-Montes; Peter J Crack; Jose L Crespo; Alfredo Criollo; Valeria Crippa; Riccardo Cristofani; Tamas Csizmadia; Antonio Cuadrado; Bing Cui; Jun Cui; Yixian Cui; Yong Cui; Emmanuel Culetto; Andrea C Cumino; Andrey V Cybulsky; Mark J Czaja; Stanislaw J Czuczwar; Stefania D'Adamo; Marcello D'Amelio; Daniela D'Arcangelo; Andrew C D'Lugos; Gabriella D'Orazi; James A da Silva; Hormos Salimi Dafsari; Ruben K Dagda; Yasin Dagdas; Maria Daglia; Xiaoxia Dai; Yun Dai; Yuyuan Dai; Jessica Dal Col; Paul Dalhaimer; Luisa Dalla Valle; Tobias Dallenga; Guillaume Dalmasso; Markus Damme; Ilaria Dando; Nico P Dantuma; April L Darling; Hiranmoy Das; Srinivasan Dasarathy; Santosh K Dasari; Srikanta Dash; Oliver Daumke; Adrian N Dauphinee; Jeffrey S Davies; Valeria A Dávila; Roger J Davis; Tanja Davis; Sharadha Dayalan Naidu; Francesca De Amicis; Karolien De Bosscher; Francesca De Felice; Lucia De Franceschi; Chiara De Leonibus; Mayara G de Mattos Barbosa; Guido R Y De Meyer; Angelo De Milito; Cosimo De Nunzio; Clara De Palma; Mauro De Santi; Claudio De Virgilio; Daniela De Zio; Jayanta Debnath; Brian J DeBosch; Jean-Paul Decuypere; Mark A Deehan; Gianluca Deflorian; James DeGregori; Benjamin Dehay; Gabriel Del Rio; Joe R Delaney; Lea M D Delbridge; Elizabeth Delorme-Axford; M Victoria Delpino; Francesca Demarchi; Vilma Dembitz; Nicholas D Demers; Hongbin Deng; Zhiqiang Deng; Joern Dengjel; Paul Dent; Donna Denton; Melvin L DePamphilis; Channing J Der; Vojo Deretic; Albert Descoteaux; Laura Devis; Sushil Devkota; Olivier Devuyst; Grant Dewson; Mahendiran Dharmasivam; Rohan Dhiman; Diego di Bernardo; Manlio Di Cristina; Fabio Di Domenico; Pietro Di Fazio; Alessio Di Fonzo; Giovanni Di Guardo; Gianni M Di Guglielmo; Luca Di Leo; Chiara Di Malta; Alessia Di Nardo; Martina Di Rienzo; Federica Di Sano; George Diallinas; Jiajie Diao; Guillermo Diaz-Araya; Inés Díaz-Laviada; Jared M Dickinson; Marc Diederich; Mélanie Dieudé; Ivan Dikic; Shiping Ding; Wen-Xing Ding; Luciana Dini; Jelena Dinić; Miroslav Dinic; Albena T Dinkova-Kostova; Marc S Dionne; Jörg H W Distler; Abhinav Diwan; Ian M C Dixon; Mojgan Djavaheri-Mergny; Ina Dobrinski; Oxana Dobrovinskaya; Radek Dobrowolski; Renwick C J Dobson; Jelena Đokić; Serap Dokmeci Emre; Massimo Donadelli; Bo Dong; Xiaonan Dong; Zhiwu Dong; Gerald W Dorn Ii; Volker Dotsch; Huan Dou; Juan Dou; Moataz Dowaidar; Sami Dridi; Liat Drucker; Ailian Du; Caigan Du; Guangwei Du; Hai-Ning Du; Li-Lin Du; André du Toit; Shao-Bin Duan; Xiaoqiong Duan; Sónia P Duarte; Anna Dubrovska; Elaine A Dunlop; Nicolas Dupont; Raúl V Durán; Bilikere S Dwarakanath; Sergey A Dyshlovoy; Darius Ebrahimi-Fakhari; Leopold Eckhart; Charles L Edelstein; Thomas Efferth; Eftekhar Eftekharpour; Ludwig Eichinger; Nabil Eid; Tobias Eisenberg; N Tony Eissa; Sanaa Eissa; Miriam Ejarque; Abdeljabar El Andaloussi; Nazira El-Hage; Shahenda El-Naggar; Anna Maria Eleuteri; Eman S El-Shafey; Mohamed Elgendy; Aristides G Eliopoulos; María M Elizalde; Philip M Elks; Hans-Peter Elsasser; Eslam S Elsherbiny; Brooke M Emerling; N C Tolga Emre; Christina H Eng; Nikolai Engedal; Anna-Mart Engelbrecht; Agnete S T Engelsen; Jorrit M Enserink; Ricardo Escalante; Audrey Esclatine; Mafalda Escobar-Henriques; Eeva-Liisa Eskelinen; Lucile Espert; Makandjou-Ola Eusebio; Gemma Fabrias; Cinzia Fabrizi; Antonio Facchiano; Francesco Facchiano; Bengt Fadeel; Claudio Fader; Alex C Faesen; W Douglas Fairlie; Alberto Falcó; Bjorn H Falkenburger; Daping Fan; Jie Fan; Yanbo Fan; Evandro F Fang; Yanshan Fang; Yognqi Fang; Manolis Fanto; Tamar Farfel-Becker; Mathias Faure; Gholamreza Fazeli; Anthony O Fedele; Arthur M Feldman; Du Feng; Jiachun Feng; Lifeng Feng; Yibin Feng; Yuchen Feng; Wei Feng; Thais Fenz Araujo; Thomas A Ferguson; Álvaro F Fernández; Jose C Fernandez-Checa; Sonia Fernández-Veledo; Alisdair R Fernie; Anthony W Ferrante; Alessandra Ferraresi; Merari F Ferrari; Julio C B Ferreira; Susan Ferro-Novick; Antonio Figueras; Riccardo Filadi; Nicoletta Filigheddu; Eduardo Filippi-Chiela; Giuseppe Filomeni; Gian Maria Fimia; Vittorio Fineschi; Francesca Finetti; Steven Finkbeiner; Edward A Fisher; Paul B Fisher; Flavio Flamigni; Steven J Fliesler; Trude H Flo; Ida Florance; Oliver Florey; Tullio Florio; Erika Fodor; Carlo Follo; Edward A Fon; Antonella Forlino; Francesco Fornai; Paola Fortini; Anna Fracassi; Alessandro Fraldi; Brunella Franco; Rodrigo Franco; Flavia Franconi; Lisa B Frankel; Scott L Friedman; Leopold F Fröhlich; Gema Frühbeck; Jose M Fuentes; Yukio Fujiki; Naonobu Fujita; Yuuki Fujiwara; Mitsunori Fukuda; Simone Fulda; Luc Furic; Norihiko Furuya; Carmela Fusco; Michaela U Gack; Lidia Gaffke; Sehamuddin Galadari; Alessia Galasso; Maria F Galindo; Sachith Gallolu Kankanamalage; Lorenzo Galluzzi; Vincent Galy; Noor Gammoh; Boyi Gan; Ian G Ganley; Feng Gao; Hui Gao; Minghui Gao; Ping Gao; Shou-Jiang Gao; Wentao Gao; Xiaobo Gao; Ana Garcera; Maria Noé Garcia; Verónica E Garcia; Francisco García-Del Portillo; Vega Garcia-Escudero; Aracely Garcia-Garcia; Marina Garcia-Macia; Diana García-Moreno; Carmen Garcia-Ruiz; Patricia García-Sanz; Abhishek D Garg; Ricardo Gargini; Tina Garofalo; Robert F Garry; Nils C Gassen; Damian Gatica; Liang Ge; Wanzhong Ge; Ruth Geiss-Friedlander; Cecilia Gelfi; Pascal Genschik; Ian E Gentle; Valeria Gerbino; Christoph Gerhardt; Kyla Germain; Marc Germain; David A Gewirtz; Elham Ghasemipour Afshar; Saeid Ghavami; Alessandra Ghigo; Manosij Ghosh; Georgios Giamas; Claudia Giampietri; Alexandra Giatromanolaki; Gary E Gibson; Spencer B Gibson; Vanessa Ginet; Edward Giniger; Carlotta Giorgi; Henrique Girao; Stephen E Girardin; Mridhula Giridharan; Sandy Giuliano; Cecilia Giulivi; Sylvie Giuriato; Julien Giustiniani; Alexander Gluschko; Veit Goder; Alexander Goginashvili; Jakub Golab; David C Goldstone; Anna Golebiewska; Luciana R Gomes; Rodrigo Gomez; Rubén Gómez-Sánchez; Maria Catalina Gomez-Puerto; Raquel Gomez-Sintes; Qingqiu Gong; Felix M Goni; Javier González-Gallego; Tomas Gonzalez-Hernandez; Rosa A Gonzalez-Polo; Jose A Gonzalez-Reyes; Patricia González-Rodríguez; Ing Swie Goping; Marina S Gorbatyuk; Nikolai V Gorbunov; Kıvanç Görgülü; Roxana M Gorojod; Sharon M Gorski; Sandro Goruppi; Cecilia Gotor; Roberta A Gottlieb; Illana Gozes; Devrim Gozuacik; Martin Graef; Markus H Gräler; Veronica Granatiero; Daniel Grasso; Joshua P Gray; Douglas R Green; Alexander Greenhough; Stephen L Gregory; Edward F Griffin; Mark W Grinstaff; Frederic Gros; Charles Grose; Angelina S Gross; Florian Gruber; Paolo Grumati; Tilman Grune; Xueyan Gu; Jun-Lin Guan; Carlos M Guardia; Kishore Guda; Flora Guerra; Consuelo Guerri; Prasun Guha; Carlos Guillén; Shashi Gujar; Anna Gukovskaya; Ilya Gukovsky; Jan Gunst; Andreas Günther; Anyonya R Guntur; Chuanyong Guo; Chun Guo; Hongqing Guo; Lian-Wang Guo; Ming Guo; Pawan Gupta; Shashi Kumar Gupta; Swapnil Gupta; Veer Bala Gupta; Vivek Gupta; Asa B Gustafsson; David D Gutterman; Ranjitha H B; Annakaisa Haapasalo; James E Haber; Aleksandra Hać; Shinji Hadano; Anders J Hafrén; Mansour Haidar; Belinda S Hall; Gunnel Halldén; Anne Hamacher-Brady; Andrea Hamann; Maho Hamasaki; Weidong Han; Malene Hansen; Phyllis I Hanson; Zijian Hao; Masaru Harada; Ljubica Harhaji-Trajkovic; Nirmala Hariharan; Nigil Haroon; James Harris; Takafumi Hasegawa; Noor Hasima Nagoor; Jeffrey A Haspel; Volker Haucke; Wayne D Hawkins; Bruce A Hay; Cole M Haynes; Soren B Hayrabedyan; Thomas S Hays; Congcong He; Qin He; Rong-Rong He; You-Wen He; Yu-Ying He; Yasser Heakal; Alexander M Heberle; J Fielding Hejtmancik; Gudmundur Vignir Helgason; Vanessa Henkel; Marc Herb; Alexander Hergovich; Anna Herman-Antosiewicz; Agustín Hernández; Carlos Hernandez; Sergio Hernandez-Diaz; Virginia Hernandez-Gea; Amaury Herpin; Judit Herreros; Javier H Hervás; Daniel Hesselson; Claudio Hetz; Volker T Heussler; Yujiro Higuchi; Sabine Hilfiker; Joseph A Hill; William S Hlavacek; Emmanuel A Ho; Idy H T Ho; Philip Wing-Lok Ho; Shu-Leong Ho; Wan Yun Ho; G Aaron Hobbs; Mark Hochstrasser; Peter H M Hoet; Daniel Hofius; Paul Hofman; Annika Höhn; Carina I Holmberg; Jose R Hombrebueno; Chang-Won Hong Yi-Ren Hong; Lora V Hooper; Thorsten Hoppe; Rastislav Horos; Yujin Hoshida; I-Lun Hsin; Hsin-Yun Hsu; Bing Hu; Dong Hu; Li-Fang Hu; Ming Chang Hu; Ronggui Hu; Wei Hu; Yu-Chen Hu; Zhuo-Wei Hu; Fang Hua; Jinlian Hua; Yingqi Hua; Chongmin Huan; Canhua Huang; Chuanshu Huang; Chuanxin Huang; Chunling Huang; Haishan Huang; Kun Huang; Michael L H Huang; Rui Huang; Shan Huang; Tianzhi Huang; Xing Huang; Yuxiang Jack Huang; Tobias B Huber; Virginie Hubert; Christian A Hubner; Stephanie M Hughes; William E Hughes; Magali Humbert; Gerhard Hummer; James H Hurley; Sabah Hussain; Salik Hussain; Patrick J Hussey; Martina Hutabarat; Hui-Yun Hwang; Seungmin Hwang; Antonio Ieni; Fumiyo Ikeda; Yusuke Imagawa; Yuzuru Imai; Carol Imbriano; Masaya Imoto; Denise M Inman; Ken Inoki; Juan Iovanna; Renato V Iozzo; Giuseppe Ippolito; Javier E Irazoqui; Pablo Iribarren; Mohd Ishaq; Makoto Ishikawa; Nestor Ishimwe; Ciro Isidoro; Nahed Ismail; Shohreh Issazadeh-Navikas; Eisuke Itakura; Daisuke Ito; Davor Ivankovic; Saška Ivanova; Anand Krishnan V Iyer; José M Izquierdo; Masanori Izumi; Marja Jäättelä; Majid Sakhi Jabir; William T Jackson; Nadia Jacobo-Herrera; Anne-Claire Jacomin; Elise Jacquin; Pooja Jadiya; Hartmut Jaeschke; Chinnaswamy Jagannath; Arjen J Jakobi; Johan Jakobsson; Bassam Janji; Pidder Jansen-Dürr; Patric J Jansson; Jonathan Jantsch; Sławomir Januszewski; Alagie Jassey; Steve Jean; Hélène Jeltsch-David; Pavla Jendelova; Andreas Jenny; Thomas E Jensen; Niels Jessen; Jenna L Jewell; Jing Ji; Lijun Jia; Rui Jia; Liwen Jiang; Qing Jiang; Richeng Jiang; Teng Jiang; Xuejun Jiang; Yu Jiang; Maria Jimenez-Sanchez; Eun-Jung Jin; Fengyan Jin; Hongchuan Jin; Li Jin; Luqi Jin; Meiyan Jin; Si Jin; Eun-Kyeong Jo; Carine Joffre; Terje Johansen; Gail V W Johnson; Simon A Johnston; Eija Jokitalo; Mohit Kumar Jolly; Leo A B Joosten; Joaquin Jordan; Bertrand Joseph; Dianwen Ju; Jeong-Sun Ju; Jingfang Ju; Esmeralda Juárez; Delphine Judith; Gábor Juhász; Youngsoo Jun; Chang Hwa Jung; Sung-Chul Jung; Yong Keun Jung; Heinz Jungbluth; Johannes Jungverdorben; Steffen Just; Kai Kaarniranta; Allen Kaasik; Tomohiro Kabuta; Daniel Kaganovich; Alon Kahana; Renate Kain; Shinjo Kajimura; Maria Kalamvoki; Manjula Kalia; Danuta S Kalinowski; Nina Kaludercic; Ioanna Kalvari; Joanna Kaminska; Vitaliy O Kaminskyy; Hiromitsu Kanamori; Keizo Kanasaki; Chanhee Kang; Rui Kang; Sang Sun Kang; Senthilvelrajan Kaniyappan; Tomotake Kanki; Thirumala-Devi Kanneganti; Anumantha G Kanthasamy; Arthi Kanthasamy; Marc Kantorow; Orsolya Kapuy; Michalis V Karamouzis; Md Razaul Karim; Parimal Karmakar; Rajesh G Katare; Masaru Kato; Stefan H E Kaufmann; Anu Kauppinen; Gur P Kaushal; Susmita Kaushik; Kiyoshi Kawasaki; Kemal Kazan; Po-Yuan Ke; Damien J Keating; Ursula Keber; John H Kehrl; Kate E Keller; Christian W Keller; Jongsook Kim Kemper; Candia M Kenific; Oliver Kepp; Stephanie Kermorgant; Andreas Kern; Robin Ketteler; Tom G Keulers; Boris Khalfin; Hany Khalil; Bilon Khambu; Shahid Y Khan; Vinoth Kumar Megraj Khandelwal; Rekha Khandia; Widuri Kho; Noopur V Khobrekar; Sataree Khuansuwan; Mukhran Khundadze; Samuel A Killackey; Dasol Kim; Deok Ryong Kim; Do-Hyung Kim; Dong-Eun Kim; Eun Young Kim; Eun-Kyoung Kim; Hak-Rim Kim; Hee-Sik Kim; Jeong Hun Kim; Jin Kyung Kim; Jin-Hoi Kim; Joungmok Kim; Ju Hwan Kim; Keun Il Kim; Peter K Kim; Seong-Jun Kim; Scot R Kimball; Adi Kimchi; Alec C Kimmelman; Tomonori Kimura; Matthew A King; Kerri J Kinghorn; Conan G Kinsey; Vladimir Kirkin; Lorrie A Kirshenbaum; Sergey L Kiselev; Shuji Kishi; Katsuhiko Kitamoto; Yasushi Kitaoka; Kaio Kitazato; Richard N Kitsis; Josef T Kittler; Ole Kjaerulff; Peter S Klein; Thomas Klopstock; Jochen Klucken; Helene Knævelsrud; Roland L Knorr; Ben C B Ko; Fred Ko; Jiunn-Liang Ko; Hotaka Kobayashi; Satoru Kobayashi; Ina Koch; Jan C Koch; Ulrich Koenig; Donat Kögel; Young Ho Koh; Masato Koike; Sepp D Kohlwein; Nur M Kocaturk; Masaaki Komatsu; Jeannette König; Toru Kono; Benjamin T Kopp; Tamas Korcsmaros; Gözde Korkmaz; Viktor I Korolchuk; Mónica Suárez Korsnes; Ali Koskela; Janaiah Kota; Yaichiro Kotake; Monica L Kotler; Yanjun Kou; Michael I Koukourakis; Evangelos Koustas; Attila L Kovacs; Tibor Kovács; Daisuke Koya; Tomohiro Kozako; Claudine Kraft; Dimitri Krainc; Helmut Krämer; Anna D Krasnodembskaya; Carole Kretz-Remy; Guido Kroemer; Nicholas T Ktistakis; Kazuyuki Kuchitsu; Sabine Kuenen; Lars Kuerschner; Thomas Kukar; Ajay Kumar; Ashok Kumar; Deepak Kumar; Dhiraj Kumar; Sharad Kumar; Shinji Kume; Caroline Kumsta; Chanakya N Kundu; Mondira Kundu; Ajaikumar B Kunnumakkara; Lukasz Kurgan; Tatiana G Kutateladze; Ozlem Kutlu; SeongAe Kwak; Ho Jeong Kwon; Taeg Kyu Kwon; Yong Tae Kwon; Irene Kyrmizi; Albert La Spada; Patrick Labonté; Sylvain Ladoire; Ilaria Laface; Frank Lafont; Diane C Lagace; Vikramjit Lahiri; Zhibing Lai; Angela S Laird; Aparna Lakkaraju; Trond Lamark; Sheng-Hui Lan; Ane Landajuela; Darius J R Lane; Jon D Lane; Charles H Lang; Carsten Lange; Ülo Langel; Rupert Langer; Pierre Lapaquette; Jocelyn Laporte; Nicholas F LaRusso; Isabel Lastres-Becker; Wilson Chun Yu Lau; Gordon W Laurie; Sergio Lavandero; Betty Yuen Kwan Law; Helen Ka-Wai Law; Rob Layfield; Weidong Le; Herve Le Stunff; Alexandre Y Leary; Jean-Jacques Lebrun; Lionel Y W Leck; Jean-Philippe Leduc-Gaudet; Changwook Lee; Chung-Pei Lee; Da-Hye Lee; Edward B Lee; Erinna F Lee; Gyun Min Lee; He-Jin Lee; Heung Kyu Lee; Jae Man Lee; Jason S Lee; Jin-A Lee; Joo-Yong Lee; Jun Hee Lee; Michael Lee; Min Goo Lee; Min Jae Lee; Myung-Shik Lee; Sang Yoon Lee; Seung-Jae Lee; Stella Y Lee; Sung Bae Lee; Won Hee Lee; Ying-Ray Lee; Yong-Ho Lee; Youngil Lee; Christophe Lefebvre; Renaud Legouis; Yu L Lei; Yuchen Lei; Sergey Leikin; Gerd Leitinger; Leticia Lemus; Shuilong Leng; Olivia Lenoir; Guido Lenz; Heinz Josef Lenz; Paola Lenzi; Yolanda León; Andréia M Leopoldino; Christoph Leschczyk; Stina Leskelä; Elisabeth Letellier; Chi-Ting Leung; Po Sing Leung; Jeremy S Leventhal; Beth Levine; Patrick A Lewis; Klaus Ley; Bin Li; Da-Qiang Li; Jianming Li; Jing Li; Jiong Li; Ke Li; Liwu Li; Mei Li; Min Li; Min Li; Ming Li; Mingchuan Li; Pin-Lan Li; Ming-Qing Li; Qing Li; Sheng Li; Tiangang Li; Wei Li; Wenming Li; Xue Li; Yi-Ping Li; Yuan Li; Zhiqiang Li; Zhiyong Li; Zhiyuan Li; Jiqin Lian; Chengyu Liang; Qiangrong Liang; Weicheng Liang; Yongheng Liang; YongTian Liang; Guanghong Liao; Lujian Liao; Mingzhi Liao; Yung-Feng Liao; Mariangela Librizzi; Pearl P Y Lie; Mary A Lilly; Hyunjung J Lim; Thania R R Lima; Federica Limana; Chao Lin; Chih-Wen Lin; Dar-Shong Lin; Fu-Cheng Lin; Jiandie D Lin; Kurt M Lin; Kwang-Huei Lin; Liang-Tzung Lin; Pei-Hui Lin; Qiong Lin; Shaofeng Lin; Su-Ju Lin; Wenyu Lin; Xueying Lin; Yao-Xin Lin; Yee-Shin Lin; Rafael Linden; Paula Lindner; Shuo-Chien Ling; Paul Lingor; Amelia K Linnemann; Yih-Cherng Liou; Marta M Lipinski; Saška Lipovšek; Vitor A Lira; Natalia Lisiak; Paloma B Liton; Chao Liu; Ching-Hsuan Liu; Chun-Feng Liu; Cui Hua Liu; Fang Liu; Hao Liu; Hsiao-Sheng Liu; Hua-Feng Liu; Huifang Liu; Jia Liu; Jing Liu; Julia Liu; Leyuan Liu; Longhua Liu; Meilian Liu; Qin Liu; Wei Liu; Wende Liu; Xiao-Hong Liu; Xiaodong Liu; Xingguo Liu; Xu Liu; Xuedong Liu; Yanfen Liu; Yang Liu; Yang Liu; Yueyang Liu; Yule Liu; J Andrew Livingston; Gerard Lizard; Jose M Lizcano; Senka Ljubojevic-Holzer; Matilde E LLeonart; David Llobet-Navàs; Alicia Llorente; Chih Hung Lo; Damián Lobato-Márquez; Qi Long; Yun Chau Long; Ben Loos; Julia A Loos; Manuela G López; Guillermo López-Doménech; José Antonio López-Guerrero; Ana T López-Jiménez; Óscar López-Pérez; Israel López-Valero; Magdalena J Lorenowicz; Mar Lorente; Peter Lorincz; Laura Lossi; Sophie Lotersztajn; Penny E Lovat; Jonathan F Lovell; Alenka Lovy; Péter Lőw; Guang Lu; Haocheng Lu; Jia-Hong Lu; Jin-Jian Lu; Mengji Lu; Shuyan Lu; Alessandro Luciani; John M Lucocq; Paula Ludovico; Micah A Luftig; Morten Luhr; Diego Luis-Ravelo; Julian J Lum; Liany Luna-Dulcey; Anders H Lund; Viktor K Lund; Jan D Lünemann; Patrick Lüningschrör; Honglin Luo; Rongcan Luo; Shouqing Luo; Zhi Luo; Claudio Luparello; Bernhard Lüscher; Luan Luu; Alex Lyakhovich; Konstantin G Lyamzaev; Alf Håkon Lystad; Lyubomyr Lytvynchuk; Alvin C Ma; Changle Ma; Mengxiao Ma; Ning-Fang Ma; Quan-Hong Ma; Xinliang Ma; Yueyun Ma; Zhenyi Ma; Ormond A MacDougald; Fernando Macian; Gustavo C MacIntosh; Jeffrey P MacKeigan; Kay F Macleod; Sandra Maday; Frank Madeo; Muniswamy Madesh; Tobias Madl; Julio Madrigal-Matute; Akiko Maeda; Yasuhiro Maejima; Marta Magarinos; Poornima Mahavadi; Emiliano Maiani; Kenneth Maiese; Panchanan Maiti; Maria Chiara Maiuri; Barbara Majello; Michael B Major; Elena Makareeva; Fayaz Malik; Karthik Mallilankaraman; Walter Malorni; Alina Maloyan; Najiba Mammadova; Gene Chi Wai Man; Federico Manai; Joseph D Mancias; Eva-Maria Mandelkow; Michael A Mandell; Angelo A Manfredi; Masoud H Manjili; Ravi Manjithaya; Patricio Manque; Bella B Manshian; Raquel Manzano; Claudia Manzoni; Kai Mao; Cinzia Marchese; Sandrine Marchetti; Anna Maria Marconi; Fabrizio Marcucci; Stefania Mardente; Olga A Mareninova; Marta Margeta; Muriel Mari; Sara Marinelli; Oliviero Marinelli; Guillermo Mariño; Sofia Mariotto; Richard S Marshall; Mark R Marten; Sascha Martens; Alexandre P J Martin; Katie R Martin; Sara Martin; Shaun Martin; Adrián Martín-Segura; Miguel A Martín-Acebes; Inmaculada Martin-Burriel; Marcos Martin-Rincon; Paloma Martin-Sanz; José A Martina; Wim Martinet; Aitor Martinez; Ana Martinez; Jennifer Martinez; Moises Martinez Velazquez; Nuria Martinez-Lopez; Marta Martinez-Vicente; Daniel O Martins; Joilson O Martins; Waleska K Martins; Tania Martins-Marques; Emanuele Marzetti; Shashank Masaldan; Celine Masclaux-Daubresse; Douglas G Mashek; Valentina Massa; Lourdes Massieu; Glenn R Masson; Laura Masuelli; Anatoliy I Masyuk; Tetyana V Masyuk; Paola Matarrese; Ander Matheu; Satoaki Matoba; Sachiko Matsuzaki; Pamela Mattar; Alessandro Matte; Domenico Mattoscio; José L Mauriz; Mario Mauthe; Caroline Mauvezin; Emanual Maverakis; Paola Maycotte; Johanna Mayer; Gianluigi Mazzoccoli; Cristina Mazzoni; Joseph R Mazzulli; Nami McCarty; Christine McDonald; Mitchell R McGill; Sharon L McKenna; BethAnn McLaughlin; Fionn McLoughlin; Mark A McNiven; Thomas G McWilliams; Fatima Mechta-Grigoriou; Tania Catarina Medeiros; Diego L Medina; Lynn A Megeney; Klara Megyeri; Maryam Mehrpour; Jawahar L Mehta; Alfred J Meijer; Annemarie H Meijer; Jakob Mejlvang; Alicia Meléndez; Annette Melk; Gonen Memisoglu; Alexandrina F Mendes; Delong Meng; Fei Meng; Tian Meng; Rubem Menna-Barreto; Manoj B Menon; Carol Mercer; Anne E Mercier; Jean-Louis Mergny; Adalberto Merighi; Seth D Merkley; Giuseppe Merla; Volker Meske; Ana Cecilia Mestre; Shree Padma Metur; Christian Meyer; Hemmo Meyer; Wenyi Mi; Jeanne Mialet-Perez; Junying Miao; Lucia Micale; Yasuo Miki; Enrico Milan; Małgorzata Milczarek; Dana L Miller; Samuel I Miller; Silke Miller; Steven W Millward; Ira Milosevic; Elena A Minina; Hamed Mirzaei; Hamid Reza Mirzaei; Mehdi Mirzaei; Amit Mishra; Nandita Mishra; Paras Kumar Mishra; Maja Misirkic Marjanovic; Roberta Misasi; Amit Misra; Gabriella Misso; Claire Mitchell; Geraldine Mitou; Tetsuji Miura; Shigeki Miyamoto; Makoto Miyazaki; Mitsunori Miyazaki; Taiga Miyazaki; Keisuke Miyazawa; Noboru Mizushima; Trine H Mogensen; Baharia Mograbi; Reza Mohammadinejad; Yasir Mohamud; Abhishek Mohanty; Sipra Mohapatra; Torsten Möhlmann; Asif Mohmmed; Anna Moles; Kelle H Moley; Maurizio Molinari; Vincenzo Mollace; Andreas Buch Møller; Bertrand Mollereau; Faustino Mollinedo; Costanza Montagna; Mervyn J Monteiro; Andrea Montella; L Ruth Montes; Barbara Montico; Vinod K Mony; Giacomo Monzio Compagnoni; Michael N Moore; Mohammad A Moosavi; Ana L Mora; Marina Mora; David Morales-Alamo; Rosario Moratalla; Paula I Moreira; Elena Morelli; Sandra Moreno; Daniel Moreno-Blas; Viviana Moresi; Benjamin Morga; Alwena H Morgan; Fabrice Morin; Hideaki Morishita; Orson L Moritz; Mariko Moriyama; Yuji Moriyasu; Manuela Morleo; Eugenia Morselli; Jose F Moruno-Manchon; Jorge Moscat; Serge Mostowy; Elisa Motori; Andrea Felinto Moura; Naima Moustaid-Moussa; Maria Mrakovcic; Gabriel Muciño-Hernández; Anupam Mukherjee; Subhadip Mukhopadhyay; Jean M Mulcahy Levy; Victoriano Mulero; Sylviane Muller; Christian Münch; Ashok Munjal; Pura Munoz-Canoves; Teresa Muñoz-Galdeano; Christian Münz; Tomokazu Murakawa; Claudia Muratori; Brona M Murphy; J Patrick Murphy; Aditya Murthy; Timo T Myöhänen; Indira U Mysorekar; Jennifer Mytych; Seyed Mohammad Nabavi; Massimo Nabissi; Péter Nagy; Jihoon Nah; Aimable Nahimana; Ichiro Nakagawa; Ken Nakamura; Hitoshi Nakatogawa; Shyam S Nandi; Meera Nanjundan; Monica Nanni; Gennaro Napolitano; Roberta Nardacci; Masashi Narita; Melissa Nassif; Ilana Nathan; Manabu Natsumeda; Ryno J Naude; Christin Naumann; Olaia Naveiras; Fatemeh Navid; Steffan T Nawrocki; Taras Y Nazarko; Francesca Nazio; Florentina Negoita; Thomas Neill; Amanda L Neisch; Luca M Neri; Mihai G Netea; Patrick Neubert; Thomas P Neufeld; Dietbert Neumann; Albert Neutzner; Phillip T Newton; Paul A Ney; Ioannis P Nezis; Charlene C W Ng; Tzi Bun Ng; Hang T T Nguyen; Long T Nguyen; Hong-Min Ni; Clíona Ní Cheallaigh; Zhenhong Ni; M Celeste Nicolao; Francesco Nicoli; Manuel Nieto-Diaz; Per Nilsson; Shunbin Ning; Rituraj Niranjan; Hiroshi Nishimune; Mireia Niso-Santano; Ralph A Nixon; Annalisa Nobili; Clevio Nobrega; Takeshi Noda; Uxía Nogueira-Recalde; Trevor M Nolan; Ivan Nombela; Ivana Novak; Beatriz Novoa; Takashi Nozawa; Nobuyuki Nukina; Carmen Nussbaum-Krammer; Jesper Nylandsted; Tracey R O'Donovan; Seónadh M O'Leary; Eyleen J O'Rourke; Mary P O'Sullivan; Timothy E O'Sullivan; Salvatore Oddo; Ina Oehme; Michinaga Ogawa; Eric Ogier-Denis; Margret H Ogmundsdottir; Besim Ogretmen; Goo Taeg Oh; Seon-Hee Oh; Young J Oh; Takashi Ohama; Yohei Ohashi; Masaki Ohmuraya; Vasileios Oikonomou; Rani Ojha; Koji Okamoto; Hitoshi Okazawa; Masahide Oku; Sara Oliván; Jorge M A Oliveira; Michael Ollmann; James A Olzmann; Shakib Omari; M Bishr Omary; Gizem Önal; Martin Ondrej; Sang-Bing Ong; Sang-Ging Ong; Anna Onnis; Juan A Orellana; Sara Orellana-Muñoz; Maria Del Mar Ortega-Villaizan; Xilma R Ortiz-Gonzalez; Elena Ortona; Heinz D Osiewacz; Abdel-Hamid K Osman; Rosario Osta; Marisa S Otegui; Kinya Otsu; Christiane Ott; Luisa Ottobrini; Jing-Hsiung James Ou; Tiago F Outeiro; Inger Oynebraten; Melek Ozturk; Gilles Pagès; Susanta Pahari; Marta Pajares; Utpal B Pajvani; Rituraj Pal; Simona Paladino; Nicolas Pallet; Michela Palmieri; Giuseppe Palmisano; Camilla Palumbo; Francesco Pampaloni; Lifeng Pan; Qingjun Pan; Wenliang Pan; Xin Pan; Ganna Panasyuk; Rahul Pandey; Udai B Pandey; Vrajesh Pandya; Francesco Paneni; Shirley Y Pang; Elisa Panzarini; Daniela L Papademetrio; Elena Papaleo; Daniel Papinski; Diana Papp; Eun Chan Park; Hwan Tae Park; Ji-Man Park; Jong-In Park; Joon Tae Park; Junsoo Park; Sang Chul Park; Sang-Youel Park; Abraham H Parola; Jan B Parys; Adrien Pasquier; Benoit Pasquier; João F Passos; Nunzia Pastore; Hemal H Patel; Daniel Patschan; Sophie Pattingre; Gustavo Pedraza-Alva; Jose Pedraza-Chaverri; Zully Pedrozo; Gang Pei; Jianming Pei; Hadas Peled-Zehavi; Joaquín M Pellegrini; Joffrey Pelletier; Miguel A Peñalva; Di Peng; Ying Peng; Fabio Penna; Maria Pennuto; Francesca Pentimalli; Cláudia Mf Pereira; Gustavo J S Pereira; Lilian C Pereira; Luis Pereira de Almeida; Nirma D Perera; Ángel Pérez-Lara; Ana B Perez-Oliva; María Esther Pérez-Pérez; Palsamy Periyasamy; Andras Perl; Cristiana Perrotta; Ida Perrotta; Richard G Pestell; Morten Petersen; Irina Petrache; Goran Petrovski; Thorsten Pfirrmann; Astrid S Pfister; Jennifer A Philips; Huifeng Pi; Anna Picca; Alicia M Pickrell; Sandy Picot; Giovanna M Pierantoni; Marina Pierdominici; Philippe Pierre; Valérie Pierrefite-Carle; Karolina Pierzynowska; Federico Pietrocola; Miroslawa Pietruczuk; Claudio Pignata; Felipe X Pimentel-Muiños; Mario Pinar; Roberta O Pinheiro; Ronit Pinkas-Kramarski; Paolo Pinton; Karolina Pircs; Sujan Piya; Paola Pizzo; Theo S Plantinga; Harald W Platta; Ainhoa Plaza-Zabala; Markus Plomann; Egor Y Plotnikov; Helene Plun-Favreau; Ryszard Pluta; Roger Pocock; Stefanie Pöggeler; Christian Pohl; Marc Poirot; Angelo Poletti; Marisa Ponpuak; Hana Popelka; Blagovesta Popova; Helena Porta; Soledad Porte Alcon; Eliana Portilla-Fernandez; Martin Post; Malia B Potts; Joanna Poulton; Ted Powers; Veena Prahlad; Tomasz K Prajsnar; Domenico Praticò; Rosaria Prencipe; Muriel Priault; Tassula Proikas-Cezanne; Vasilis J Promponas; Christopher G Proud; Rosa Puertollano; Luigi Puglielli; Thomas Pulinilkunnil; Deepika Puri; Rajat Puri; Julien Puyal; Xiaopeng Qi; Yongmei Qi; Wenbin Qian; Lei Qiang; Yu Qiu; Joe Quadrilatero; Jorge Quarleri; Nina Raben; Hannah Rabinowich; Debora Ragona; Michael J Ragusa; Nader Rahimi; Marveh Rahmati; Valeria Raia; Nuno Raimundo; Namakkal-Soorappan Rajasekaran; Sriganesh Ramachandra Rao; Abdelhaq Rami; Ignacio Ramírez-Pardo; David B Ramsden; Felix Randow; Pundi N Rangarajan; Danilo Ranieri; Hai Rao; Lang Rao; Rekha Rao; Sumit Rathore; J Arjuna Ratnayaka; Edward A Ratovitski; Palaniyandi Ravanan; Gloria Ravegnini; Swapan K Ray; Babak Razani; Vito Rebecca; Fulvio Reggiori; Anne Régnier-Vigouroux; Andreas S Reichert; David Reigada; Jan H Reiling; Theo Rein; Siegfried Reipert; Rokeya Sultana Rekha; Hongmei Ren; Jun Ren; Weichao Ren; Tristan Renault; Giorgia Renga; Karen Reue; Kim Rewitz; Bruna Ribeiro de Andrade Ramos; S Amer Riazuddin; Teresa M Ribeiro-Rodrigues; Jean-Ehrland Ricci; Romeo Ricci; Victoria Riccio; Des R Richardson; Yasuko Rikihisa; Makarand V Risbud; Ruth M Risueño; Konstantinos Ritis; Salvatore Rizza; Rosario Rizzuto; Helen C Roberts; Luke D Roberts; Katherine J Robinson; Maria Carmela Roccheri; Stephane Rocchi; George G Rodney; Tiago Rodrigues; Vagner Ramon Rodrigues Silva; Amaia Rodriguez; Ruth Rodriguez-Barrueco; Nieves Rodriguez-Henche; Humberto Rodriguez-Rocha; Jeroen Roelofs; Robert S Rogers; Vladimir V Rogov; Ana I Rojo; Krzysztof Rolka; Vanina Romanello; Luigina Romani; Alessandra Romano; Patricia S Romano; David Romeo-Guitart; Luis C Romero; Montserrat Romero; Joseph C Roney; Christopher Rongo; Sante Roperto; Mathias T Rosenfeldt; Philip Rosenstiel; Anne G Rosenwald; Kevin A Roth; Lynn Roth; Steven Roth; Kasper M A Rouschop; Benoit D Roussel; Sophie Roux; Patrizia Rovere-Querini; Ajit Roy; Aurore Rozieres; Diego Ruano; David C Rubinsztein; Maria P Rubtsova; Klaus Ruckdeschel; Christoph Ruckenstuhl; Emil Rudolf; Rüdiger Rudolf; Alessandra Ruggieri; Avnika Ashok Ruparelia; Paola Rusmini; Ryan R Russell; Gian Luigi Russo; Maria Russo; Rossella Russo; Oxana O Ryabaya; Kevin M Ryan; Kwon-Yul Ryu; Maria Sabater-Arcis; Ulka Sachdev; Michael Sacher; Carsten Sachse; Abhishek Sadhu; Junichi Sadoshima; Nathaniel Safren; Paul Saftig; Antonia P Sagona; Gaurav Sahay; Amirhossein Sahebkar; Mustafa Sahin; Ozgur Sahin; Sumit Sahni; Nayuta Saito; Shigeru Saito; Tsunenori Saito; Ryohei Sakai; Yasuyoshi Sakai; Jun-Ichi Sakamaki; Kalle Saksela; Gloria Salazar; Anna Salazar-Degracia; Ghasem H Salekdeh; Ashok K Saluja; Belém Sampaio-Marques; Maria Cecilia Sanchez; Jose A Sanchez-Alcazar; Victoria Sanchez-Vera; Vanessa Sancho-Shimizu; J Thomas Sanderson; Marco Sandri; Stefano Santaguida; Laura Santambrogio; Magda M Santana; Giorgio Santoni; Alberto Sanz; Pascual Sanz; Shweta Saran; Marco Sardiello; Timothy J Sargeant; Apurva Sarin; Chinmoy Sarkar; Sovan Sarkar; Maria-Rosa Sarrias; Surajit Sarkar; Dipanka Tanu Sarmah; Jaakko Sarparanta; Aishwarya Sathyanarayan; Ranganayaki Sathyanarayanan; K Matthew Scaglione; Francesca Scatozza; Liliana Schaefer; Zachary T Schafer; Ulrich E Schaible; Anthony H V Schapira; Michael Scharl; Hermann M Schatzl; Catherine H Schein; Wiep Scheper; David Scheuring; Maria Vittoria Schiaffino; Monica Schiappacassi; Rainer Schindl; Uwe Schlattner; Oliver Schmidt; Roland Schmitt; Stephen D Schmidt; Ingo Schmitz; Eran Schmukler; Anja Schneider; Bianca E Schneider; Romana Schober; Alejandra C Schoijet; Micah B Schott; Michael Schramm; Bernd Schröder; Kai Schuh; Christoph Schüller; Ryan J Schulze; Lea Schürmanns; Jens C Schwamborn; Melanie Schwarten; Filippo Scialo; Sebastiano Sciarretta; Melanie J Scott; Kathleen W Scotto; A Ivana Scovassi; Andrea Scrima; Aurora Scrivo; David Sebastian; Salwa Sebti; Simon Sedej; Laura Segatori; Nava Segev; Per O Seglen; Iban Seiliez; Ekihiro Seki; Scott B Selleck; Frank W Sellke; Joshua T Selsby; Michael Sendtner; Serif Senturk; Elena Seranova; Consolato Sergi; Ruth Serra-Moreno; Hiromi Sesaki; Carmine Settembre; Subba Rao Gangi Setty; Gianluca Sgarbi; Ou Sha; John J Shacka; Javeed A Shah; Dantong Shang; Changshun Shao; Feng Shao; Soroush Sharbati; Lisa M Sharkey; Dipali Sharma; Gaurav Sharma; Kulbhushan Sharma; Pawan Sharma; Surendra Sharma; Han-Ming Shen; Hongtao Shen; Jiangang Shen; Ming Shen; Weili Shen; Zheni Shen; Rui Sheng; Zhi Sheng; Zu-Hang Sheng; Jianjian Shi; Xiaobing Shi; Ying-Hong Shi; Kahori Shiba-Fukushima; Jeng-Jer Shieh; Yohta Shimada; Shigeomi Shimizu; Makoto Shimozawa; Takahiro Shintani; Christopher J Shoemaker; Shahla Shojaei; Ikuo Shoji; Bhupendra V Shravage; Viji Shridhar; Chih-Wen Shu; Hong-Bing Shu; Ke Shui; Arvind K Shukla; Timothy E Shutt; Valentina Sica; Aleem Siddiqui; Amanda Sierra; Virginia Sierra-Torre; Santiago Signorelli; Payel Sil; Bruno J de Andrade Silva; Johnatas D Silva; Eduardo Silva-Pavez; Sandrine Silvente-Poirot; Rachel E Simmonds; Anna Katharina Simon; Hans-Uwe Simon; Matias Simons; Anurag Singh; Lalit P Singh; Rajat Singh; Shivendra V Singh; Shrawan K Singh; Sudha B Singh; Sunaina Singh; Surinder Pal Singh; Debasish Sinha; Rohit Anthony Sinha; Sangita Sinha; Agnieszka Sirko; Kapil Sirohi; Efthimios L Sivridis; Panagiotis Skendros; Aleksandra Skirycz; Iva Slaninová; Soraya S Smaili; Andrei Smertenko; Matthew D Smith; Stefaan J Soenen; Eun Jung Sohn; Sophia P M Sok; Giancarlo Solaini; Thierry Soldati; Scott A Soleimanpour; Rosa M Soler; Alexei Solovchenko; Jason A Somarelli; Avinash Sonawane; Fuyong Song; Hyun Kyu Song; Ju-Xian Song; Kunhua Song; Zhiyin Song; Leandro R Soria; Maurizio Sorice; Alexander A Soukas; Sandra-Fausia Soukup; Diana Sousa; Nadia Sousa; Paul A Spagnuolo; Stephen A Spector; M M Srinivas Bharath; Daret St Clair; Venturina Stagni; Leopoldo Staiano; Clint A Stalnecker; Metodi V Stankov; Peter B Stathopulos; Katja Stefan; Sven Marcel Stefan; Leonidas Stefanis; Joan S Steffan; Alexander Steinkasserer; Harald Stenmark; Jared Sterneckert; Craig Stevens; Veronika Stoka; Stephan Storch; Björn Stork; Flavie Strappazzon; Anne Marie Strohecker; Dwayne G Stupack; Huanxing Su; Ling-Yan Su; Longxiang Su; Ana M Suarez-Fontes; Carlos S Subauste; Selvakumar Subbian; Paula V Subirada; Ganapasam Sudhandiran; Carolyn M Sue; Xinbing Sui; Corey Summers; Guangchao Sun; Jun Sun; Kang Sun; Meng-Xiang Sun; Qiming Sun; Yi Sun; Zhongjie Sun; Karen K S Sunahara; Eva Sundberg; Katalin Susztak; Peter Sutovsky; Hidekazu Suzuki; Gary Sweeney; J David Symons; Stephen Cho Wing Sze; Nathaniel J Szewczyk; Anna Tabęcka-Łonczynska; Claudio Tabolacci; Frank Tacke; Heinrich Taegtmeyer; Marco Tafani; Mitsuo Tagaya; Haoran Tai; Stephen W G Tait; Yoshinori Takahashi; Szabolcs Takats; Priti Talwar; Chit Tam; Shing Yau Tam; Davide Tampellini; Atsushi Tamura; Chong Teik Tan; Eng-King Tan; Ya-Qin Tan; Masaki Tanaka; Motomasa Tanaka; Daolin Tang; Jingfeng Tang; Tie-Shan Tang; Isei Tanida; Zhipeng Tao; Mohammed Taouis; Lars Tatenhorst; Nektarios Tavernarakis; Allen Taylor; Gregory A Taylor; Joan M Taylor; Elena Tchetina; Andrew R Tee; Irmgard Tegeder; David Teis; Natercia Teixeira; Fatima Teixeira-Clerc; Kumsal A Tekirdag; Tewin Tencomnao; Sandra Tenreiro; Alexei V Tepikin; Pilar S Testillano; Gianluca Tettamanti; Pierre-Louis Tharaux; Kathrin Thedieck; Arvind A Thekkinghat; Stefano Thellung; Josephine W Thinwa; V P Thirumalaikumar; Sufi Mary Thomas; Paul G Thomes; Andrew Thorburn; Lipi Thukral; Thomas Thum; Michael Thumm; Ling Tian; Ales Tichy; Andreas Till; Vincent Timmerman; Vladimir I Titorenko; Sokol V Todi; Krassimira Todorova; Janne M Toivonen; Luana Tomaipitinca; Dhanendra Tomar; Cristina Tomas-Zapico; Sergej Tomić; Benjamin Chun-Kit Tong; Chao Tong; Xin Tong; Sharon A Tooze; Maria L Torgersen; Satoru Torii; Liliana Torres-López; Alicia Torriglia; Christina G Towers; Roberto Towns; Shinya Toyokuni; Vladimir Trajkovic; Donatella Tramontano; Quynh-Giao Tran; Leonardo H Travassos; Charles B Trelford; Shirley Tremel; Ioannis P Trougakos; Betty P Tsao; Mario P Tschan; Hung-Fat Tse; Tak Fu Tse; Hitoshi Tsugawa; Andrey S Tsvetkov; David A Tumbarello; Yasin Tumtas; María J Tuñón; Sandra Turcotte; Boris Turk; Vito Turk; Bradley J Turner; Richard I Tuxworth; Jessica K Tyler; Elena V Tyutereva; Yasuo Uchiyama; Aslihan Ugun-Klusek; Holm H Uhlig; Marzena Ułamek-Kozioł; Ilya V Ulasov; Midori Umekawa; Christian Ungermann; Rei Unno; Sylvie Urbe; Elisabet Uribe-Carretero; Suayib Üstün; Vladimir N Uversky; Thomas Vaccari; Maria I Vaccaro; Björn F Vahsen; Helin Vakifahmetoglu-Norberg; Rut Valdor; Maria J Valente; Ayelén Valko; Richard B Vallee; Angela M Valverde; Greet Van den Berghe; Stijn van der Veen; Luc Van Kaer; Jorg van Loosdregt; Sjoerd J L van Wijk; Wim Vandenberghe; Ilse Vanhorebeek; Marcos A Vannier-Santos; Nicola Vannini; M Cristina Vanrell; Chiara Vantaggiato; Gabriele Varano; Isabel Varela-Nieto; Máté Varga; M Helena Vasconcelos; Somya Vats; Demetrios G Vavvas; Ignacio Vega-Naredo; Silvia Vega-Rubin-de-Celis; Guillermo Velasco; Ariadna P Velázquez; Tibor Vellai; Edo Vellenga; Francesca Velotti; Mireille Verdier; Panayotis Verginis; Isabelle Vergne; Paul Verkade; Manish Verma; Patrik Verstreken; Tim Vervliet; Jörg Vervoorts; Alexandre T Vessoni; Victor M Victor; Michel Vidal; Chiara Vidoni; Otilia V Vieira; Richard D Vierstra; Sonia Viganó; Helena Vihinen; Vinoy Vijayan; Miquel Vila; Marçal Vilar; José M Villalba; Antonio Villalobo; Beatriz Villarejo-Zori; Francesc Villarroya; Joan Villarroya; Olivier Vincent; Cecile Vindis; Christophe Viret; Maria Teresa Viscomi; Dora Visnjic; Ilio Vitale; David J Vocadlo; Olga V Voitsekhovskaja; Cinzia Volonté; Mattia Volta; Marta Vomero; Clarissa Von Haefen; Marc A Vooijs; Wolfgang Voos; Ljubica Vucicevic; Richard Wade-Martins; Satoshi Waguri; Kenrick A Waite; Shuji Wakatsuki; David W Walker; Mark J Walker; Simon A Walker; Jochen Walter; Francisco G Wandosell; Bo Wang; Chao-Yung Wang; Chen Wang; Chenran Wang; Chenwei Wang; Cun-Yu Wang; Dong Wang; Fangyang Wang; Feng Wang; Fengming Wang; Guansong Wang; Han Wang; Hao Wang; Hexiang Wang; Hong-Gang Wang; Jianrong Wang; Jigang Wang; Jiou Wang; Jundong Wang; Kui Wang; Lianrong Wang; Liming Wang; Maggie Haitian Wang; Meiqing Wang; Nanbu Wang; Pengwei Wang; Peipei Wang; Ping Wang; Ping Wang; Qing Jun Wang; Qing Wang; Qing Kenneth Wang; Qiong A Wang; Wen-Tao Wang; Wuyang Wang; Xinnan Wang; Xuejun Wang; Yan Wang; Yanchang Wang; Yanzhuang Wang; Yen-Yun Wang; Yihua Wang; Yipeng Wang; Yu Wang; Yuqi Wang; Zhe Wang; Zhenyu Wang; Zhouguang Wang; Gary Warnes; Verena Warnsmann; Hirotaka Watada; Eizo Watanabe; Maxinne Watchon; Anna Wawrzyńska; Timothy E Weaver; Grzegorz Wegrzyn; Ann M Wehman; Huafeng Wei; Lei Wei; Taotao Wei; Yongjie Wei; Oliver H Weiergräber; Conrad C Weihl; Günther Weindl; Ralf Weiskirchen; Alan Wells; Runxia H Wen; Xin Wen; Antonia Werner; Beatrice Weykopf; Sally P Wheatley; J Lindsay Whitton; Alexander J Whitworth; Katarzyna Wiktorska; Manon E Wildenberg; Tom Wileman; Simon Wilkinson; Dieter Willbold; Brett Williams; Robin S B Williams; Roger L Williams; Peter R Williamson; Richard A Wilson; Beate Winner; Nathaniel J Winsor; Steven S Witkin; Harald Wodrich; Ute Woehlbier; Thomas Wollert; Esther Wong; Jack Ho Wong; Richard W Wong; Vincent Kam Wai Wong; W Wei-Lynn Wong; An-Guo Wu; Chengbiao Wu; Jian Wu; Junfang Wu; Kenneth K Wu; Min Wu; Shan-Ying Wu; Shengzhou Wu; Shu-Yan Wu; Shufang Wu; William K K Wu; Xiaohong Wu; Xiaoqing Wu; Yao-Wen Wu; Yihua Wu; Ramnik J Xavier; Hongguang Xia; Lixin Xia; Zhengyuan Xia; Ge Xiang; Jin Xiang; Mingliang Xiang; Wei Xiang; Bin Xiao; Guozhi Xiao; Hengyi Xiao; Hong-Tao Xiao; Jian Xiao; Lan Xiao; Shi Xiao; Yin Xiao; Baoming Xie; Chuan-Ming Xie; Min Xie; Yuxiang Xie; Zhiping Xie; Zhonglin Xie; Maria Xilouri; Congfeng Xu; En Xu; Haoxing Xu; Jing Xu; JinRong Xu; Liang Xu; Wen Wen Xu; Xiulong Xu; Yu Xue; Sokhna M S Yakhine-Diop; Masamitsu Yamaguchi; Osamu Yamaguchi; Ai Yamamoto; Shunhei Yamashina; Shengmin Yan; Shian-Jang Yan; Zhen Yan; Yasuo Yanagi; Chuanbin Yang; Dun-Sheng Yang; Huan Yang; Huang-Tian Yang; Hui Yang; Jin-Ming Yang; Jing Yang; Jingyu Yang; Ling Yang; Liu Yang; Ming Yang; Pei-Ming Yang; Qian Yang; Seungwon Yang; Shu Yang; Shun-Fa Yang; Wannian Yang; Wei Yuan Yang; Xiaoyong Yang; Xuesong Yang; Yi Yang; Ying Yang; Honghong Yao; Shenggen Yao; Xiaoqiang Yao; Yong-Gang Yao; Yong-Ming Yao; Takahiro Yasui; Meysam Yazdankhah; Paul M Yen; Cong Yi; Xiao-Ming Yin; Yanhai Yin; Zhangyuan Yin; Ziyi Yin; Meidan Ying; Zheng Ying; Calvin K Yip; Stephanie Pei Tung Yiu; Young H Yoo; Kiyotsugu Yoshida; Saori R Yoshii; Tamotsu Yoshimori; Bahman Yousefi; Boxuan Yu; Haiyang Yu; Jun Yu; Jun Yu; Li Yu; Ming-Lung Yu; Seong-Woon Yu; Victor C Yu; W Haung Yu; Zhengping Yu; Zhou Yu; Junying Yuan; Ling-Qing Yuan; Shilin Yuan; Shyng-Shiou F Yuan; Yanggang Yuan; Zengqiang Yuan; Jianbo Yue; Zhenyu Yue; Jeanho Yun; Raymond L Yung; David N Zacks; Gabriele Zaffagnini; Vanessa O Zambelli; Isabella Zanella; Qun S Zang; Sara Zanivan; Silvia Zappavigna; Pilar Zaragoza; Konstantinos S Zarbalis; Amir Zarebkohan; Amira Zarrouk; Scott O Zeitlin; Jialiu Zeng; Ju-Deng Zeng; Eva Žerovnik; Lixuan Zhan; Bin Zhang; Donna D Zhang; Hanlin Zhang; Hong Zhang; Hong Zhang; Honghe Zhang; Huafeng Zhang; Huaye Zhang; Hui Zhang; Hui-Ling Zhang; Jianbin Zhang; Jianhua Zhang; Jing-Pu Zhang; Kalin Y B Zhang; Leshuai W Zhang; Lin Zhang; Lisheng Zhang; Lu Zhang; Luoying Zhang; Menghuan Zhang; Peng Zhang; Sheng Zhang; Wei Zhang; Xiangnan Zhang; Xiao-Wei Zhang; Xiaolei Zhang; Xiaoyan Zhang; Xin Zhang; Xinxin Zhang; Xu Dong Zhang; Yang Zhang; Yanjin Zhang; Yi Zhang; Ying-Dong Zhang; Yingmei Zhang; Yuan-Yuan Zhang; Yuchen Zhang; Zhe Zhang; Zhengguang Zhang; Zhibing Zhang; Zhihai Zhang; Zhiyong Zhang; Zili Zhang; Haobin Zhao; Lei Zhao; Shuang Zhao; Tongbiao Zhao; Xiao-Fan Zhao; Ying Zhao; Yongchao Zhao; Yongliang Zhao; Yuting Zhao; Guoping Zheng; Kai Zheng; Ling Zheng; Shizhong Zheng; Xi-Long Zheng; Yi Zheng; Zu-Guo Zheng; Boris Zhivotovsky; Qing Zhong; Ao Zhou; Ben Zhou; Cefan Zhou; Gang Zhou; Hao Zhou; Hong Zhou; Hongbo Zhou; Jie Zhou; Jing Zhou; Jing Zhou; Jiyong Zhou; Kailiang Zhou; Rongjia Zhou; Xu-Jie Zhou; Yanshuang Zhou; Yinghong Zhou; Yubin Zhou; Zheng-Yu Zhou; Zhou Zhou; Binglin Zhu; Changlian Zhu; Guo-Qing Zhu; Haining Zhu; Hongxin Zhu; Hua Zhu; Wei-Guo Zhu; Yanping Zhu; Yushan Zhu; Haixia Zhuang; Xiaohong Zhuang; Katarzyna Zientara-Rytter; Christine M Zimmermann; Elena Ziviani; Teresa Zoladek; Wei-Xing Zong; Dmitry B Zorov; Antonio Zorzano; Weiping Zou; Zhen Zou; Zhengzhi Zou; Steven Zuryn; Werner Zwerschke; Beate Brand-Saberi; X Charlie Dong; Chandra Shekar Kenchappa; Zuguo Li; Yong Lin; Shigeru Oshima; Yueguang Rong; Judith C Sluimer; Christina L Stallings; Chun-Kit Tong
Journal:  Autophagy       Date:  2021-02-08       Impact factor: 13.391

Review 3.  HSPA8/HSC70 in Immune Disorders: A Molecular Rheostat that Adjusts Chaperone-Mediated Autophagy Substrates.

Authors:  Srinivasa Reddy Bonam; Marc Ruff; Sylviane Muller
Journal:  Cells       Date:  2019-08-07       Impact factor: 6.600

Review 4.  Lysosomes as a therapeutic target.

Authors:  Srinivasa Reddy Bonam; Fengjuan Wang; Sylviane Muller
Journal:  Nat Rev Drug Discov       Date:  2019-09-02       Impact factor: 84.694

Review 5.  The HSP Immune Network in Cancer.

Authors:  Zarema Albakova; Yana Mangasarova
Journal:  Front Immunol       Date:  2021-11-30       Impact factor: 7.561

Review 6.  With or without You: Co-Chaperones Mediate Health and Disease by Modifying Chaperone Function and Protein Triage.

Authors:  Selin Altinok; Rebekah Sanchez-Hodge; Mariah Stewart; Kaitlan Smith; Jonathan C Schisler
Journal:  Cells       Date:  2021-11-11       Impact factor: 7.666

Review 7.  Similarities and Differences of Hsp70, hsc70, Grp78 and Mortalin as Cancer Biomarkers and Drug Targets.

Authors:  Rajani Rai; Amy L Kennedy; Zitha Redempta Isingizwe; Pouya Javadian; Doris Mangiaracina Benbrook
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

Review 8.  HSP70 and HSP90 in Cancer: Cytosolic, Endoplasmic Reticulum and Mitochondrial Chaperones of Tumorigenesis.

Authors:  Zarema Albakova; Yana Mangasarova; Akhmet Albakov; Liliya Gorenkova
Journal:  Front Oncol       Date:  2022-01-21       Impact factor: 6.244

Review 9.  Regulation of stress signaling pathways by protein lipoxidation.

Authors:  Tommi Patinen; Simone Adinolfi; Carlos Cruz Cortés; Jouni Härkönen; Ashik Jawahar Deen; Anna-Liisa Levonen
Journal:  Redox Biol       Date:  2019-01-16       Impact factor: 11.799

10.  In Vivo Remodeling of Altered Autophagy-Lysosomal Pathway by a Phosphopeptide in Lupus.

Authors:  Fengjuan Wang; Inmaculada Tasset; Ana Maria Cuervo; Sylviane Muller
Journal:  Cells       Date:  2020-10-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.